Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-590-3p AASS 2.59 0 -1.35 5.0E-5 MirTarget; miRanda -0.3 0 NA
2 hsa-miR-590-3p ABAT 2.59 0 -0.34 0.43051 PITA; miRanda -0.27 0.00042 NA
3 hsa-miR-590-3p ABCA6 2.59 0 -2.84 1.0E-5 MirTarget; miRanda -0.47 2.0E-5 NA
4 hsa-miR-590-3p ABCA8 2.59 0 -5.33 0 miRanda -0.89 0 NA
5 hsa-miR-590-3p ABCA9 2.59 0 -3.14 0 miRanda -0.71 0 NA
6 hsa-miR-590-3p ABCB1 2.59 0 -2.33 0 miRanda -0.29 1.0E-5 NA
7 hsa-miR-590-3p ABCB4 2.59 0 -1.92 0 miRanda -0.4 0 NA
8 hsa-miR-590-3p ABCC4 2.59 0 -1.54 1.0E-5 mirMAP -0.25 2.0E-5 NA
9 hsa-miR-590-3p ABCC9 2.59 0 -2.76 0 miRanda; mirMAP -0.64 0 NA
10 hsa-miR-590-3p ABCD2 2.59 0 -3.08 0 MirTarget; miRanda; mirMAP -0.35 3.0E-5 NA
11 hsa-miR-590-3p ABHD2 2.59 0 -0.37 0.12248 miRanda; mirMAP -0.15 0.00026 NA
12 hsa-miR-590-3p ABI2 2.59 0 -0.65 0 miRanda; mirMAP -0.11 0 NA
13 hsa-miR-590-3p ABI3BP 2.59 0 -4.28 0 miRanda -0.81 0 NA
14 hsa-miR-590-3p ABLIM1 2.59 0 -1.72 0 miRanda; mirMAP -0.17 0.0006 NA
15 hsa-miR-590-3p ACADSB 2.59 0 -1 0.00017 MirTarget; miRanda; mirMAP -0.19 5.0E-5 NA
16 hsa-miR-590-3p ACAT1 2.59 0 -1.05 0 mirMAP -0.13 0.00058 NA
17 hsa-miR-590-3p ACOT1 2.59 0 -0.69 0.00048 miRanda -0.21 0 NA
18 hsa-miR-590-3p ACOT2 2.59 0 -0.56 0.00263 miRanda -0.17 0 NA
19 hsa-miR-590-3p ACOX2 2.59 0 -3.75 0 miRanda -0.71 0 NA
20 hsa-miR-590-3p ACSS3 2.59 0 -2.48 1.0E-5 miRanda -0.58 0 NA
21 hsa-miR-590-3p ACTB 2.59 0 -0.54 0.00046 miRanda -0.1 0.00016 NA
22 hsa-miR-590-3p ACTC1 2.59 0 -7.19 0 miRanda -1.76 0 NA
23 hsa-miR-590-3p ACTG2 2.59 0 -5.39 0 miRanda -1.27 0 NA
24 hsa-miR-590-3p ACTN1 2.59 0 -1.05 0.00011 miRanda; miRNATAP -0.33 0 NA
25 hsa-miR-590-3p ACVR1 2.59 0 -0.44 0.01143 miRanda -0.2 0 NA
26 hsa-miR-590-3p ADAM12 2.59 0 0.88 0.05623 mirMAP -0.23 0.00464 NA
27 hsa-miR-590-3p ADAM19 2.59 0 -1.06 0.01895 miRanda -0.23 0.00353 NA
28 hsa-miR-590-3p ADAM32 2.59 0 -0.49 0.23688 miRanda -0.16 0.0295 NA
29 hsa-miR-590-3p ADAM33 2.59 0 -4.48 0 miRanda -0.8 0 NA
30 hsa-miR-590-3p ADAM9 2.59 0 -0.2 0.40665 miRanda; mirMAP -0.17 4.0E-5 NA
31 hsa-miR-590-3p ADAMTS1 2.59 0 -3.81 0 miRanda -0.59 0 NA
32 hsa-miR-590-3p ADAMTS14 2.59 0 0.61 0.12479 miRanda -0.14 0.03948 NA
33 hsa-miR-590-3p ADAMTS16 2.59 0 -1.54 0.01905 miRanda; mirMAP -0.77 0 NA
34 hsa-miR-590-3p ADAMTS17 2.59 0 -1.24 0.00463 miRanda -0.2 0.01117 NA
35 hsa-miR-590-3p ADAMTS18 2.59 0 -0.74 0.14599 PITA; miRanda; miRNATAP -0.43 0 NA
36 hsa-miR-590-3p ADAMTS3 2.59 0 -1.18 0.00448 miRanda; mirMAP -0.21 0.00422 NA
37 hsa-miR-590-3p ADAMTS5 2.59 0 -2.16 0 PITA; miRanda; miRNATAP -0.4 0 NA
38 hsa-miR-590-3p ADAMTS6 2.59 0 -0.88 0.01914 miRanda -0.27 6.0E-5 NA
39 hsa-miR-590-3p ADAMTS8 2.59 0 -4.33 0 miRanda -0.94 0 NA
40 hsa-miR-590-3p ADAMTS9 2.59 0 -1.79 0 miRanda -0.36 0 NA
41 hsa-miR-590-3p ADAMTSL1 2.59 0 -2.52 0 miRanda; mirMAP -0.49 0 NA
42 hsa-miR-590-3p ADAMTSL3 2.59 0 -5.11 0 miRanda -0.92 0 NA
43 hsa-miR-590-3p ADAMTSL5 2.59 0 -0.41 0.32739 miRanda -0.15 0.03422 NA
44 hsa-miR-590-3p ADARB1 2.59 0 -1.93 0 miRanda; mirMAP -0.44 0 NA
45 hsa-miR-590-3p ADCY2 2.59 0 -3.87 0 mirMAP -0.75 0 NA
46 hsa-miR-590-3p ADCY9 2.59 0 -1.5 0 miRanda -0.26 0 NA
47 hsa-miR-590-3p ADCYAP1 2.59 0 -3.51 0 MirTarget; PITA; miRanda; miRNATAP -0.71 0 NA
48 hsa-miR-590-3p ADD1 2.59 0 -0.81 0 MirTarget; PITA; miRanda; miRNATAP -0.14 0 NA
49 hsa-miR-590-3p ADH1A 2.59 0 -4.53 0 miRanda -0.6 0 NA
50 hsa-miR-590-3p ADH1B 2.59 0 -7.89 0 miRanda; mirMAP -1.26 0 NA
51 hsa-miR-590-3p ADH1C 2.59 0 -3.38 7.0E-5 miRanda -0.46 0.00247 NA
52 hsa-miR-590-3p ADIPOQ 2.59 0 -5.02 0 PITA; miRanda; mirMAP -1.12 0 NA
53 hsa-miR-590-3p AFAP1 2.59 0 -0.98 0.00012 PITA; miRanda; miRNATAP -0.22 0 NA
54 hsa-miR-590-3p AFF2 2.59 0 -1.73 0.00201 PITA; miRanda; mirMAP; miRNATAP -0.25 0.01122 NA
55 hsa-miR-590-3p AFF3 2.59 0 -5 0 PITA; miRanda; mirMAP; miRNATAP -0.79 0 NA
56 hsa-miR-590-3p AFF4 2.59 0 -0.82 0 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.11 2.0E-5 NA
57 hsa-miR-590-3p AGL 2.59 0 -0.67 6.0E-5 PITA; miRanda; mirMAP; miRNATAP -0.12 6.0E-5 NA
58 hsa-miR-590-3p AGT 2.59 0 -1.62 0.00168 miRanda -0.31 0.0007 NA
59 hsa-miR-590-3p AGTR1 2.59 0 -4.49 0 miRanda -1.09 0 NA
60 hsa-miR-590-3p AHNAK 2.59 0 -1.66 0 miRanda -0.32 0 NA
61 hsa-miR-590-3p AK5 2.59 0 -1.18 0.03248 miRanda; mirMAP -0.21 0.02614 NA
62 hsa-miR-590-3p AKAP11 2.59 0 -0.8 0 MirTarget; miRanda; miRNATAP -0.17 0 NA
63 hsa-miR-590-3p AKAP12 2.59 0 -2.95 0 miRanda; mirMAP -0.41 0 NA
64 hsa-miR-590-3p AKAP13 2.59 0 -1.15 0 PITA; miRanda; mirMAP -0.25 0 NA
65 hsa-miR-590-3p AKAP2 2.59 0 -2.51 8.0E-5 mirMAP -0.47 3.0E-5 NA
66 hsa-miR-590-3p AKAP3 2.59 0 -0.31 0.33219 PITA; miRanda; miRNATAP -0.15 0.0071 NA
67 hsa-miR-590-3p AKAP6 2.59 0 -3.34 0 MirTarget; PITA; miRanda; mirMAP -0.77 0 NA
68 hsa-miR-590-3p AKAP7 2.59 0 -1.26 1.0E-5 miRanda; mirMAP -0.13 0.01132 NA
69 hsa-miR-590-3p ALAD 2.59 0 -0.66 0 miRanda -0.1 1.0E-5 NA
70 hsa-miR-590-3p ALDH1A1 2.59 0 -2.52 2.0E-5 miRanda -0.22 0.03678 NA
71 hsa-miR-590-3p ALDH1A3 2.59 0 -1.34 0.0022 miRanda; mirMAP -0.21 0.00696 NA
72 hsa-miR-590-3p ALDH1L1 2.59 0 -2.2 0.00265 miRanda -0.39 0.00245 NA
73 hsa-miR-590-3p ALDH1L2 2.59 0 -1.12 0.02448 MirTarget; miRanda; mirMAP -0.31 0.00041 NA
74 hsa-miR-590-3p ALDH6A1 2.59 0 -0.99 1.0E-5 miRanda -0.18 0 NA
75 hsa-miR-590-3p ALDH7A1 2.59 0 -1.69 0.00179 miRanda; mirMAP -0.32 0.00084 NA
76 hsa-miR-590-3p ALOX5AP 2.59 0 -1.09 0.01747 miRanda -0.2 0.01067 NA
77 hsa-miR-590-3p ALPK3 2.59 0 -1.02 0.00049 miRanda; mirMAP -0.39 0 NA
78 hsa-miR-590-3p AMIGO1 2.59 0 -0.87 0.00139 miRanda -0.17 0.00032 NA
79 hsa-miR-590-3p AMN1 2.59 0 -0.48 0.00493 MirTarget; miRanda -0.1 0.00063 NA
80 hsa-miR-590-3p AMOT 2.59 0 -1.51 0.00385 mirMAP -0.24 0.00792 NA
81 hsa-miR-590-3p AMOTL1 2.59 0 -1.62 0 mirMAP -0.31 0 NA
82 hsa-miR-590-3p AMOTL2 2.59 0 -1.01 0.00015 miRanda -0.27 0 NA
83 hsa-miR-590-3p AMT 2.59 0 -1.03 0.00302 miRanda -0.2 0.00111 NA
84 hsa-miR-590-3p ANG 2.59 0 -1.34 0 miRanda -0.25 0 NA
85 hsa-miR-590-3p ANGPT1 2.59 0 -2 1.0E-5 PITA; miRanda; mirMAP -0.27 0.0007 NA
86 hsa-miR-590-3p ANGPTL1 2.59 0 -4.51 0 PITA; miRanda; mirMAP -1.04 0 NA
87 hsa-miR-590-3p ANK2 2.59 0 -4.32 0 MirTarget; PITA; miRanda -0.66 0 NA
88 hsa-miR-590-3p ANK3 2.59 0 -0.29 0.31896 MirTarget; PITA; miRanda; mirMAP -0.13 0.01426 NA
89 hsa-miR-590-3p ANKAR 2.59 0 -0.59 0.0026 miRanda; mirMAP -0.17 0 NA
90 hsa-miR-590-3p ANKDD1A 2.59 0 -0.7 0.00587 PITA; miRanda -0.1 0.02124 NA
91 hsa-miR-590-3p ANKFN1 2.59 0 -1.54 0.01399 miRanda -0.24 0.02738 NA
92 hsa-miR-590-3p ANKH 2.59 0 -0.38 0.21654 mirMAP; miRNATAP -0.15 0.0043 NA
93 hsa-miR-590-3p ANKRD29 2.59 0 -3.47 0 mirMAP -0.49 0 NA
94 hsa-miR-590-3p ANKRD44 2.59 0 -1.93 0 miRanda -0.3 0 NA
95 hsa-miR-590-3p ANKRD50 2.59 0 -0.88 0.00174 PITA; miRanda; mirMAP -0.25 0 NA
96 hsa-miR-590-3p ANKRD6 2.59 0 -0.77 0.00185 miRanda; mirMAP -0.11 0.00892 NA
97 hsa-miR-590-3p ANKS1A 2.59 0 -0.38 0.09203 PITA; miRanda -0.1 0.00934 NA
98 hsa-miR-590-3p ANKS1B 2.59 0 -3.65 0 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.67 0 NA
99 hsa-miR-590-3p ANO2 2.59 0 -1.39 2.0E-5 miRanda -0.15 0.00973 NA
100 hsa-miR-590-3p ANO4 2.59 0 -2.45 0 miRanda -0.25 0.00601 NA
101 hsa-miR-590-3p ANO5 2.59 0 -3.19 0 miRanda; mirMAP -0.79 0 NA
102 hsa-miR-590-3p ANO6 2.59 0 -0.74 3.0E-5 MirTarget; miRanda; mirMAP -0.19 0 NA
103 hsa-miR-590-3p ANTXR1 2.59 0 -0.71 0.0159 miRanda; mirMAP -0.39 0 NA
104 hsa-miR-590-3p ANTXR2 2.59 0 -2.31 0 PITA; miRanda; mirMAP; miRNATAP -0.56 0 NA
105 hsa-miR-590-3p ANXA5 2.59 0 -0.59 0.02508 miRanda; mirMAP; miRNATAP -0.13 0.00548 NA
106 hsa-miR-590-3p AOX1 2.59 0 -5.28 0 miRanda -0.92 0 NA
107 hsa-miR-590-3p AP1S2 2.59 0 -1.31 0 miRanda; mirMAP -0.2 0 NA
108 hsa-miR-590-3p APBB2 2.59 0 -0.59 0.0014 MirTarget; miRanda; mirMAP; miRNATAP -0.19 0 NA
109 hsa-miR-590-3p APC 2.59 0 -0.6 0.00012 PITA; miRanda; mirMAP; miRNATAP -0.1 0.00028 NA
110 hsa-miR-590-3p APCDD1L 2.59 0 -2.55 0.0003 miRanda -0.6 0 NA
111 hsa-miR-590-3p APP 2.59 0 -0.4 0.04288 miRanda -0.17 0 NA
112 hsa-miR-590-3p AR 2.59 0 -3.3 0 mirMAP; miRNATAP -0.62 0 NA
113 hsa-miR-590-3p ARHGAP10 2.59 0 -1.37 0 miRanda -0.25 0 NA
114 hsa-miR-590-3p ARHGAP24 2.59 0 -2.02 0 miRanda; mirMAP -0.42 0 NA
115 hsa-miR-590-3p ARHGAP28 2.59 0 -1.54 0.00053 mirMAP -0.18 0.01853 NA
116 hsa-miR-590-3p ARHGAP31 2.59 0 -1.16 2.0E-5 miRanda; mirMAP; miRNATAP -0.25 0 NA
117 hsa-miR-590-3p ARHGAP5 2.59 0 -0.63 0.00047 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.12 0.00023 NA
118 hsa-miR-590-3p ARHGEF10 2.59 0 -1.15 1.0E-5 miRanda; mirMAP -0.23 0 NA
119 hsa-miR-590-3p ARHGEF10L 2.59 0 -0.23 0.32891 miRanda -0.12 0.0037 NA
120 hsa-miR-590-3p ARHGEF12 2.59 0 -0.64 4.0E-5 PITA; miRanda; mirMAP; miRNATAP -0.14 0 NA
121 hsa-miR-590-3p ARHGEF15 2.59 0 -1.38 0 miRanda; mirMAP -0.25 0 NA
122 hsa-miR-590-3p ARHGEF3 2.59 0 -0.76 0 mirMAP -0.16 0 NA
123 hsa-miR-590-3p ARHGEF37 2.59 0 -1.85 0 mirMAP -0.32 0 NA
124 hsa-miR-590-3p ARHGEF6 2.59 0 -1.32 0 miRanda; mirMAP -0.22 1.0E-5 NA
125 hsa-miR-590-3p ARHGEF9 2.59 0 -1.21 0 PITA; miRanda; mirMAP; miRNATAP -0.23 0 NA
126 hsa-miR-590-3p ARID4A 2.59 0 -0.76 0 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.13 0 NA
127 hsa-miR-590-3p ARID5B 2.59 0 -1.57 0 mirMAP -0.29 0 NA
128 hsa-miR-590-3p ARL10 2.59 0 -1.12 0.00198 mirMAP -0.17 0.007 NA
129 hsa-miR-590-3p ARL15 2.59 0 -0.61 0.00667 miRanda; mirMAP -0.19 0 NA
130 hsa-miR-590-3p ARL6IP5 2.59 0 -0.43 0.00802 miRanda; mirMAP; miRNATAP -0.15 0 NA
131 hsa-miR-590-3p ARMC9 2.59 0 -0.17 0.43502 MirTarget; miRanda -0.19 0 NA
132 hsa-miR-590-3p ARMCX2 2.59 0 -0.81 0.03093 miRanda -0.16 0.01807 NA
133 hsa-miR-590-3p ARMCX3 2.59 0 -0.36 0.05476 PITA; miRanda; mirMAP -0.11 0.00093 NA
134 hsa-miR-590-3p ARNT2 2.59 0 -1.45 0.00019 PITA; miRanda; miRNATAP -0.17 0.01429 NA
135 hsa-miR-590-3p ARRDC3 2.59 0 -0.71 0.00062 mirMAP -0.14 6.0E-5 NA
136 hsa-miR-590-3p ARRDC4 2.59 0 -1.43 0 PITA; miRanda; mirMAP -0.33 0 NA
137 hsa-miR-590-3p ARSB 2.59 0 -0.58 0.00052 PITA; miRanda; mirMAP; miRNATAP -0.18 0 NA
138 hsa-miR-590-3p ARSD 2.59 0 -0.18 0.51046 miRanda -0.11 0.02022 NA
139 hsa-miR-590-3p ARSE 2.59 0 -0.31 0.54389 miRanda -0.3 0.00085 NA
140 hsa-miR-590-3p ARSG 2.59 0 -0.67 0.01125 mirMAP -0.15 0.0013 NA
141 hsa-miR-590-3p ARSJ 2.59 0 -1.58 0.00066 miRanda; mirMAP -0.27 0.00112 NA
142 hsa-miR-590-3p ART4 2.59 0 -1.65 0.00419 miRanda -0.46 0 NA
143 hsa-miR-590-3p ASAH1 2.59 0 -0.59 0.00556 miRanda; miRNATAP -0.11 0.00287 NA
144 hsa-miR-590-3p ASB5 2.59 0 -6.18 0 miRanda; mirMAP -1.46 0 NA
145 hsa-miR-590-3p ASH1L 2.59 0 -0.67 0.00016 MirTarget; PITA; miRanda; miRNATAP -0.12 0.00013 NA
146 hsa-miR-590-3p ASPA 2.59 0 -4.76 0 miRanda; mirMAP -0.71 0 NA
147 hsa-miR-590-3p ASPN 2.59 0 0.18 0.73898 miRanda -0.61 0 NA
148 hsa-miR-590-3p ASXL3 2.59 0 -3.34 0 mirMAP -0.66 0 NA
149 hsa-miR-590-3p ATE1 2.59 0 -1.09 3.0E-5 MirTarget; miRanda; mirMAP -0.17 0.00023 NA
150 hsa-miR-590-3p ATF2 2.59 0 -0.36 0.09137 MirTarget; miRanda; mirMAP; miRNATAP -0.12 0.00194 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 309 1672 1.702e-34 5.782e-31
2 CARDIOVASCULAR SYSTEM DEVELOPMENT 186 788 3.728e-34 5.782e-31
3 CIRCULATORY SYSTEM DEVELOPMENT 186 788 3.728e-34 5.782e-31
4 BIOLOGICAL ADHESION 218 1032 2.019e-32 2.348e-29
5 CELL DEVELOPMENT 271 1426 3.748e-32 3.488e-29
6 REGULATION OF CELL DIFFERENTIATION 276 1492 1.015e-30 7.869e-28
7 NEUROGENESIS 264 1402 1.273e-30 8.181e-28
8 TISSUE DEVELOPMENT 279 1518 1.407e-30 8.181e-28
9 VASCULATURE DEVELOPMENT 126 469 7.095e-29 3.668e-26
10 RESPONSE TO ENDOGENOUS STIMULUS 264 1450 3.258e-28 1.516e-25
11 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 219 1142 2.02e-26 8.546e-24
12 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 200 1008 4.787e-26 1.856e-23
13 REGULATION OF CELLULAR COMPONENT MOVEMENT 165 771 3.212e-25 1.15e-22
14 REGULATION OF CELL DEVELOPMENT 174 836 4.058e-25 1.349e-22
15 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 248 1395 6.463e-25 1.895e-22
16 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 199 1021 6.515e-25 1.895e-22
17 BLOOD VESSEL MORPHOGENESIS 101 364 1.639e-24 4.485e-22
18 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 157 750 5.511e-23 1.425e-20
19 REGULATION OF NEURON DIFFERENTIATION 127 554 2.693e-22 6.594e-20
20 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 161 799 9.236e-22 2.149e-19
21 LOCOMOTION 202 1114 2.48e-21 5.495e-19
22 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 233 1360 3.201e-21 6.769e-19
23 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 269 1656 4.377e-21 8.854e-19
24 HEART DEVELOPMENT 111 466 5.499e-21 1.066e-18
25 POSITIVE REGULATION OF CELL DIFFERENTIATION 162 823 8.164e-21 1.519e-18
26 REGULATION OF PHOSPHORUS METABOLIC PROCESS 263 1618 1.196e-20 2.141e-18
27 MUSCLE STRUCTURE DEVELOPMENT 105 432 1.311e-20 2.259e-18
28 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 117 513 1.987e-20 3.302e-18
29 RESPONSE TO OXYGEN CONTAINING COMPOUND 233 1381 2.39e-20 3.835e-18
30 RESPONSE TO HORMONE 169 893 7.517e-20 1.166e-17
31 ORGAN MORPHOGENESIS 161 841 1.899e-19 2.851e-17
32 REGULATION OF SYSTEM PROCESS 114 507 2.016e-19 2.931e-17
33 NEGATIVE REGULATION OF CELL COMMUNICATION 206 1192 3.147e-19 4.437e-17
34 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 175 957 6.234e-19 8.532e-17
35 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 215 1275 9.181e-19 1.221e-16
36 POSITIVE REGULATION OF MOLECULAR FUNCTION 277 1791 1.194e-18 1.543e-16
37 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 138 689 1.571e-18 1.976e-16
38 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 153 801 1.992e-18 2.377e-16
39 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 177 983 1.976e-18 2.377e-16
40 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 282 1848 3.606e-18 4.195e-16
41 NEURON DIFFERENTIATION 162 874 3.724e-18 4.226e-16
42 CELLULAR COMPONENT MORPHOGENESIS 165 900 5.315e-18 5.888e-16
43 REGULATION OF NEURON PROJECTION DEVELOPMENT 96 408 6.363e-18 6.885e-16
44 EXTRACELLULAR STRUCTURE ORGANIZATION 79 304 1.337e-17 1.414e-15
45 CENTRAL NERVOUS SYSTEM DEVELOPMENT 160 872 1.63e-17 1.686e-15
46 REGULATION OF CELL PROJECTION ORGANIZATION 117 558 2.03e-17 2.054e-15
47 REGULATION OF PROTEIN MODIFICATION PROCESS 263 1710 2.208e-17 2.186e-15
48 POSITIVE REGULATION OF RESPONSE TO STIMULUS 288 1929 3.126e-17 3.03e-15
49 ANGIOGENESIS 76 293 6.217e-17 5.904e-15
50 RESPONSE TO ORGANIC CYCLIC COMPOUND 164 917 7.599e-17 7.071e-15
51 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 98 437 8.903e-17 8.123e-15
52 CELL MOTILITY 153 835 9.921e-17 8.394e-15
53 LOCALIZATION OF CELL 153 835 9.921e-17 8.394e-15
54 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 113 541 9.839e-17 8.394e-15
55 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 113 541 9.839e-17 8.394e-15
56 POSITIVE REGULATION OF CELL DEVELOPMENT 103 472 1.049e-16 8.715e-15
57 EPITHELIUM DEVELOPMENT 167 945 1.238e-16 9.801e-15
58 HEAD DEVELOPMENT 136 709 1.225e-16 9.801e-15
59 REGULATION OF CELL PROLIFERATION 235 1496 1.243e-16 9.801e-15
60 RESPONSE TO WOUNDING 115 563 2.912e-16 2.258e-14
61 CELLULAR RESPONSE TO NITROGEN COMPOUND 106 505 6.373e-16 4.861e-14
62 INTRACELLULAR SIGNAL TRANSDUCTION 241 1572 8.934e-16 6.705e-14
63 CELLULAR RESPONSE TO HORMONE STIMULUS 112 552 1.187e-15 8.764e-14
64 RESPONSE TO NITROGEN COMPOUND 153 859 1.293e-15 9.401e-14
65 NEURON DEVELOPMENT 130 687 1.801e-15 1.289e-13
66 BEHAVIOR 106 516 2.964e-15 2.089e-13
67 TUBE DEVELOPMENT 111 552 3.074e-15 2.135e-13
68 REGULATION OF MAPK CASCADE 125 660 6.019e-15 4.118e-13
69 SINGLE ORGANISM BEHAVIOR 86 384 7.678e-15 5.178e-13
70 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 173 1036 8.18e-15 5.286e-13
71 NEURON PROJECTION DEVELOPMENT 109 545 8.099e-15 5.286e-13
72 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 173 1036 8.18e-15 5.286e-13
73 RESPONSE TO GROWTH FACTOR 99 475 9.585e-15 6.11e-13
74 POSITIVE REGULATION OF LOCOMOTION 91 420 1.048e-14 6.591e-13
75 NEGATIVE REGULATION OF PHOSPHORYLATION 91 422 1.416e-14 8.783e-13
76 REGULATION OF TRANSPORT 263 1804 1.822e-14 1.115e-12
77 CELL PROJECTION ORGANIZATION 155 902 1.991e-14 1.203e-12
78 POSITIVE REGULATION OF CELL COMMUNICATION 231 1532 2.494e-14 1.488e-12
79 UROGENITAL SYSTEM DEVELOPMENT 72 299 2.618e-14 1.542e-12
80 POSITIVE REGULATION OF NEURON DIFFERENTIATION 73 306 2.891e-14 1.682e-12
81 MUSCLE SYSTEM PROCESS 69 282 3.926e-14 2.255e-12
82 TISSUE MORPHOGENESIS 105 533 7.135e-14 4.049e-12
83 TAXIS 95 464 1.043e-13 5.848e-12
84 RESPONSE TO LIPID 151 888 1.07e-13 5.926e-12
85 NEURON PROJECTION MORPHOGENESIS 86 402 1.22e-13 6.677e-12
86 REGULATION OF BLOOD CIRCULATION 70 295 1.298e-13 7.024e-12
87 RESPONSE TO STEROID HORMONE 99 497 1.854e-13 9.917e-12
88 POSITIVE REGULATION OF CATALYTIC ACTIVITY 226 1518 1.929e-13 1.02e-11
89 CELL CELL ADHESION 114 608 1.995e-13 1.043e-11
90 SKELETAL SYSTEM DEVELOPMENT 93 455 2.115e-13 1.094e-11
91 REGULATION OF GTPASE ACTIVITY 122 673 3.274e-13 1.674e-11
92 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 80 368 3.625e-13 1.833e-11
93 MUSCLE TISSUE DEVELOPMENT 66 275 3.703e-13 1.853e-11
94 REGULATION OF HYDROLASE ACTIVITY 202 1327 5.243e-13 2.568e-11
95 NEGATIVE REGULATION OF CELL DIFFERENTIATION 113 609 5.24e-13 2.568e-11
96 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 75 337 5.757e-13 2.79e-11
97 POSITIVE REGULATION OF MAPK CASCADE 94 470 5.985e-13 2.871e-11
98 SYNAPSE ORGANIZATION 44 145 6.666e-13 3.165e-11
99 REGULATION OF CELL MORPHOGENESIS 105 552 7.25e-13 3.408e-11
100 REGULATION OF CELL DEATH 218 1472 9.37e-13 4.36e-11
101 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 180 1152 1.122e-12 5.17e-11
102 MUSCLE CELL DIFFERENTIATION 59 237 1.263e-12 5.76e-11
103 REGULATION OF MUSCLE SYSTEM PROCESS 52 195 1.595e-12 7.203e-11
104 EMBRYO DEVELOPMENT 148 894 1.647e-12 7.368e-11
105 MUSCLE ORGAN DEVELOPMENT 65 277 1.665e-12 7.38e-11
106 SECOND MESSENGER MEDIATED SIGNALING 46 160 1.72e-12 7.552e-11
107 POSITIVE REGULATION OF TRANSPORT 153 936 1.885e-12 8.199e-11
108 DEVELOPMENTAL GROWTH 73 333 2.557e-12 1.101e-10
109 RESPONSE TO EXTERNAL STIMULUS 256 1821 2.656e-12 1.123e-10
110 BONE DEVELOPMENT 45 156 2.634e-12 1.123e-10
111 GROWTH 84 410 2.748e-12 1.152e-10
112 REGULATION OF KINASE ACTIVITY 132 776 4.052e-12 1.684e-10
113 CIRCULATORY SYSTEM PROCESS 77 366 5.71e-12 2.351e-10
114 MESENCHYME DEVELOPMENT 50 190 7.277e-12 2.97e-10
115 REGULATION OF HEART CONTRACTION 55 221 7.373e-12 2.983e-10
116 POSITIVE REGULATION OF GENE EXPRESSION 244 1733 8.089e-12 3.245e-10
117 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 41 138 8.623e-12 3.429e-10
118 WOUND HEALING 91 470 9.306e-12 3.669e-10
119 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 143 876 1.158e-11 4.529e-10
120 RESPONSE TO ABIOTIC STIMULUS 161 1024 1.178e-11 4.57e-10
121 NEGATIVE REGULATION OF LOCOMOTION 61 263 1.358e-11 5.179e-10
122 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 67 303 1.35e-11 5.179e-10
123 HEART MORPHOGENESIS 53 212 1.468e-11 5.554e-10
124 RESPONSE TO OXYGEN LEVELS 68 311 1.627e-11 6.105e-10
125 POSITIVE REGULATION OF HYDROLASE ACTIVITY 146 905 1.702e-11 6.337e-10
126 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 56 232 1.76e-11 6.5e-10
127 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 215 1492 1.961e-11 7.186e-10
128 SENSORY ORGAN DEVELOPMENT 93 493 2.469e-11 8.976e-10
129 REGULATION OF ION TRANSPORT 106 592 2.644e-11 9.535e-10
130 REGULATION OF MEMBRANE POTENTIAL 72 343 3.111e-11 1.114e-09
131 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 55 229 3.278e-11 1.164e-09
132 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 247 1784 3.367e-11 1.187e-09
133 STRIATED MUSCLE CELL DIFFERENTIATION 46 173 3.395e-11 1.188e-09
134 REGULATION OF ACTIN FILAMENT BASED PROCESS 67 312 5.308e-11 1.843e-09
135 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 55 232 5.605e-11 1.932e-09
136 CONNECTIVE TISSUE DEVELOPMENT 49 194 5.787e-11 1.98e-09
137 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 108 616 6.311e-11 2.143e-09
138 REGULATION OF RESPONSE TO WOUNDING 81 413 6.734e-11 2.27e-09
139 CELL PART MORPHOGENESIS 110 633 7.254e-11 2.428e-09
140 SYSTEM PROCESS 245 1785 9.834e-11 3.268e-09
141 MORPHOGENESIS OF A BRANCHING STRUCTURE 44 167 1.25e-10 4.124e-09
142 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 170 1135 1.602e-10 5.25e-09
143 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 83 437 2.078e-10 6.715e-09
144 REGULATION OF VASCULATURE DEVELOPMENT 54 233 2.067e-10 6.715e-09
145 CARDIAC MUSCLE TISSUE DEVELOPMENT 39 140 2.344e-10 7.523e-09
146 REGULATION OF DEVELOPMENTAL GROWTH 62 289 2.886e-10 9.199e-09
147 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 245 1805 2.951e-10 9.342e-09
148 STEM CELL DIFFERENTIATION 47 190 3.032e-10 9.533e-09
149 REGULATION OF GROWTH 108 633 3.267e-10 1.02e-08
150 REGULATION OF METAL ION TRANSPORT 67 325 3.39e-10 1.052e-08
151 PROTEIN PHOSPHORYLATION 146 944 3.728e-10 1.149e-08
152 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 60 278 4.346e-10 1.33e-08
153 REGULATION OF CELL ADHESION 107 629 4.706e-10 1.431e-08
154 DEVELOPMENTAL CELL GROWTH 27 77 5.053e-10 1.527e-08
155 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 90 498 5.266e-10 1.581e-08
156 CELLULAR RESPONSE TO ACID CHEMICAL 44 175 6.371e-10 1.9e-08
157 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 49 207 6.54e-10 1.938e-08
158 TUBE MORPHOGENESIS 66 323 6.766e-10 1.992e-08
159 EMBRYONIC MORPHOGENESIS 95 539 6.867e-10 2.01e-08
160 MESENCHYMAL CELL DIFFERENTIATION 37 134 8.838e-10 2.57e-08
161 EMBRYONIC ORGAN DEVELOPMENT 77 406 1.005e-09 2.905e-08
162 RESPIRATORY SYSTEM DEVELOPMENT 47 197 1.103e-09 3.168e-08
163 ENDOTHELIUM DEVELOPMENT 29 90 1.151e-09 3.287e-08
164 REGULATION OF EPITHELIAL CELL PROLIFERATION 60 285 1.209e-09 3.429e-08
165 REGULATION OF EPITHELIAL CELL MIGRATION 42 166 1.263e-09 3.561e-08
166 COGNITION 55 251 1.286e-09 3.605e-08
167 FOREBRAIN DEVELOPMENT 70 357 1.341e-09 3.738e-08
168 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 151 1004 1.365e-09 3.781e-08
169 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 119 740 1.68e-09 4.625e-08
170 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 84 465 2.035e-09 5.571e-08
171 ACTIN FILAMENT BASED PROCESS 82 450 2.082e-09 5.666e-08
172 RESPONSE TO ALCOHOL 70 362 2.482e-09 6.715e-08
173 CELL ACTIVATION 97 568 2.521e-09 6.78e-08
174 RESPONSE TO CORTICOSTEROID 43 176 2.572e-09 6.878e-08
175 REGULATION OF TRANSFERASE ACTIVITY 143 946 2.726e-09 7.208e-08
176 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 23 62 2.719e-09 7.208e-08
177 MORPHOGENESIS OF AN EPITHELIUM 75 400 2.802e-09 7.365e-08
178 CELL SUBSTRATE ADHESION 41 164 2.902e-09 7.585e-08
179 MUSCLE CELL DEVELOPMENT 35 128 3.319e-09 8.627e-08
180 NEGATIVE REGULATION OF CELL PROLIFERATION 106 643 3.405e-09 8.801e-08
181 EPITHELIAL CELL DIFFERENTIATION 87 495 4.154e-09 1.063e-07
182 CELL GROWTH 36 135 4.159e-09 1.063e-07
183 MUSCLE CONTRACTION 51 233 5.285e-09 1.344e-07
184 CARDIAC MUSCLE CELL DIFFERENTIATION 25 74 5.319e-09 1.345e-07
185 SINGLE ORGANISM CELL ADHESION 82 459 5.385e-09 1.354e-07
186 POSITIVE REGULATION OF CELL PROLIFERATION 126 814 6.008e-09 1.503e-07
187 CARDIOCYTE DIFFERENTIATION 29 96 6.15e-09 1.53e-07
188 LEARNING 35 131 6.442e-09 1.589e-07
189 EYE DEVELOPMENT 64 326 6.453e-09 1.589e-07
190 RESPONSE TO ACID CHEMICAL 63 319 6.656e-09 1.63e-07
191 RESPONSE TO INORGANIC SUBSTANCE 84 479 8.559e-09 2.085e-07
192 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 44 190 9.818e-09 2.379e-07
193 NEGATIVE REGULATION OF TRANSPORT 81 458 1.068e-08 2.575e-07
194 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 157 1087 1.11e-08 2.662e-07
195 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 30 104 1.121e-08 2.675e-07
196 NEGATIVE REGULATION OF MOLECULAR FUNCTION 156 1079 1.158e-08 2.75e-07
197 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 138 926 1.303e-08 3.067e-07
198 NEURON PROJECTION GUIDANCE 46 205 1.305e-08 3.067e-07
199 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 38 153 1.32e-08 3.085e-07
200 REGULATION OF CELLULAR LOCALIZATION 178 1277 1.575e-08 3.665e-07
201 NEGATIVE REGULATION OF CELL DEATH 131 872 1.904e-08 4.408e-07
202 REGULATION OF TRANSMEMBRANE TRANSPORT 76 426 2.07e-08 4.769e-07
203 CELLULAR RESPONSE TO LIPID 80 457 2.097e-08 4.806e-07
204 ORGAN GROWTH 23 68 2.109e-08 4.809e-07
205 CALCIUM MEDIATED SIGNALING 27 90 2.397e-08 5.441e-07
206 REGULATION OF BODY FLUID LEVELS 86 506 2.548e-08 5.755e-07
207 REGULATION OF CELLULAR COMPONENT BIOGENESIS 118 767 2.626e-08 5.877e-07
208 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 36 144 2.627e-08 5.877e-07
209 GLOMERULUS DEVELOPMENT 19 49 2.798e-08 6.229e-07
210 SYNAPSE ASSEMBLY 23 69 2.886e-08 6.395e-07
211 REGULATED EXOCYTOSIS 48 224 3e-08 6.617e-07
212 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 45 204 3.231e-08 7.092e-07
213 NEGATIVE REGULATION OF CELL DEVELOPMENT 59 303 3.391e-08 7.407e-07
214 REGULATION OF TRANSPORTER ACTIVITY 44 198 3.637e-08 7.907e-07
215 MUSCLE HYPERTROPHY 14 28 3.919e-08 8.48e-07
216 GLAND DEVELOPMENT 71 395 4.414e-08 9.508e-07
217 RHYTHMIC PROCESS 58 298 4.495e-08 9.639e-07
218 NEURON MIGRATION 30 110 4.595e-08 9.808e-07
219 REGULATION OF MUSCLE CONTRACTION 36 147 4.654e-08 9.889e-07
220 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 91 554 5.275e-08 1.116e-06
221 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 45 208 5.958e-08 1.254e-06
222 NEGATIVE REGULATION OF KINASE ACTIVITY 51 250 6.093e-08 1.277e-06
223 REGULATION OF CALCIUM ION TRANSPORT 45 209 6.92e-08 1.444e-06
224 RESPONSE TO MECHANICAL STIMULUS 45 210 8.026e-08 1.667e-06
225 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 54 274 8.441e-08 1.746e-06
226 CARDIAC CHAMBER DEVELOPMENT 35 144 8.711e-08 1.793e-06
227 COLLAGEN FIBRIL ORGANIZATION 16 38 8.892e-08 1.807e-06
228 REGULATION OF SYNAPSE ORGANIZATION 30 113 8.881e-08 1.807e-06
229 HEMOSTASIS 59 311 8.855e-08 1.807e-06
230 REGULATION OF MAP KINASE ACTIVITY 60 319 9.471e-08 1.916e-06
231 POSITIVE REGULATION OF KINASE ACTIVITY 81 482 1.065e-07 2.144e-06
232 REGULATION OF OSSIFICATION 40 178 1.087e-07 2.18e-06
233 GLAND MORPHOGENESIS 27 97 1.35e-07 2.696e-06
234 NEPHRON DEVELOPMENT 30 115 1.356e-07 2.697e-06
235 NEGATIVE CHEMOTAXIS 16 39 1.378e-07 2.728e-06
236 CARTILAGE DEVELOPMENT 35 147 1.502e-07 2.962e-06
237 MODULATION OF SYNAPTIC TRANSMISSION 57 301 1.552e-07 3.048e-06
238 REGULATION OF HOMEOSTATIC PROCESS 76 447 1.619e-07 3.164e-06
239 AMEBOIDAL TYPE CELL MIGRATION 36 154 1.64e-07 3.189e-06
240 REPRODUCTIVE SYSTEM DEVELOPMENT 71 408 1.645e-07 3.189e-06
241 VASCULOGENESIS 20 59 1.671e-07 3.227e-06
242 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 27 98 1.7e-07 3.268e-06
243 CARDIAC CELL DEVELOPMENT 18 49 1.713e-07 3.28e-06
244 REGULATION OF ANATOMICAL STRUCTURE SIZE 79 472 1.812e-07 3.455e-06
245 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 95 602 1.875e-07 3.561e-06
246 PLATELET ACTIVATION 34 142 1.949e-07 3.687e-06
247 RESPONSE TO KETONE 40 182 2.044e-07 3.85e-06
248 CELLULAR RESPONSE TO PEPTIDE 53 274 2.078e-07 3.899e-06
249 POSITIVE REGULATION OF CELL DEATH 95 605 2.369e-07 4.427e-06
250 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 27 100 2.664e-07 4.959e-06
251 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 32 131 2.716e-07 5.034e-06
252 REGULATION OF CELL GROWTH 68 391 3.058e-07 5.646e-06
253 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 78 470 3.083e-07 5.67e-06
254 LUNG ALVEOLUS DEVELOPMENT 16 41 3.145e-07 5.761e-06
255 ENDOTHELIAL CELL DIFFERENTIATION 22 72 3.27e-07 5.967e-06
256 OUTFLOW TRACT MORPHOGENESIS 19 56 3.337e-07 6.066e-06
257 TELENCEPHALON DEVELOPMENT 46 228 3.722e-07 6.739e-06
258 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 21 67 3.742e-07 6.748e-06
259 REGULATION OF INFLAMMATORY RESPONSE 55 294 3.841e-07 6.9e-06
260 REGULATION OF ENDOTHELIAL CELL MIGRATION 29 114 3.893e-07 6.95e-06
261 POSITIVE REGULATION OF OSSIFICATION 24 84 3.899e-07 6.95e-06
262 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 32 133 3.926e-07 6.972e-06
263 POSITIVE REGULATION OF ION TRANSPORT 47 236 4.151e-07 7.288e-06
264 NEGATIVE REGULATION OF GROWTH 47 236 4.151e-07 7.288e-06
265 REGULATION OF CELL SUBSTRATE ADHESION 38 173 4.145e-07 7.288e-06
266 REGULATION OF CHEMOTAXIS 39 180 4.265e-07 7.46e-06
267 CYCLIC NUCLEOTIDE METABOLIC PROCESS 19 57 4.572e-07 7.967e-06
268 REGULATION OF SYNAPSE ASSEMBLY 23 79 4.68e-07 8.125e-06
269 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 44 216 5.013e-07 8.671e-06
270 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 27 103 5.089e-07 8.77e-06
271 DIGESTIVE SYSTEM DEVELOPMENT 34 148 5.534e-07 9.501e-06
272 SENSORY ORGAN MORPHOGENESIS 47 239 6.079e-07 1.04e-05
273 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 246 1977 6.209e-07 1.058e-05
274 CARDIAC CHAMBER MORPHOGENESIS 27 104 6.271e-07 1.062e-05
275 REGULATION OF HEART RATE 24 86 6.276e-07 1.062e-05
276 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 35 156 6.903e-07 1.159e-05
277 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 35 156 6.903e-07 1.159e-05
278 ARTERY DEVELOPMENT 22 75 7.17e-07 1.2e-05
279 NEGATIVE REGULATION OF CELL GROWTH 37 170 7.433e-07 1.24e-05
280 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 39 184 7.706e-07 1.281e-05
281 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 21 70 8.461e-07 1.401e-05
282 FAT CELL DIFFERENTIATION 27 106 9.428e-07 1.556e-05
283 PHOSPHORYLATION 164 1228 9.591e-07 1.577e-05
284 SMOOTH MUSCLE CELL DIFFERENTIATION 13 30 9.762e-07 1.594e-05
285 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 119 829 9.765e-07 1.594e-05
286 OVULATION CYCLE PROCESS 24 88 9.925e-07 1.609e-05
287 REGULATION OF CATION CHANNEL ACTIVITY 24 88 9.925e-07 1.609e-05
288 RESPONSE TO PEPTIDE 68 404 1.041e-06 1.683e-05
289 CHEMICAL HOMEOSTASIS 124 874 1.067e-06 1.719e-05
290 IN UTERO EMBRYONIC DEVELOPMENT 56 311 1.081e-06 1.734e-05
291 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 36 166 1.142e-06 1.826e-05
292 PLATELET DEGRANULATION 27 107 1.15e-06 1.833e-05
293 REGULATION OF ION HOMEOSTASIS 41 201 1.168e-06 1.855e-05
294 CALCIUM ION TRANSPORT 44 223 1.25e-06 1.978e-05
295 REGULATION OF CARDIAC MUSCLE CONTRACTION 20 66 1.287e-06 2.023e-05
296 REGULATION OF CARDIAC CONDUCTION 20 66 1.287e-06 2.023e-05
297 REGULATION OF ERK1 AND ERK2 CASCADE 46 238 1.321e-06 2.07e-05
298 SMOOTH MUSCLE CONTRACTION 16 45 1.377e-06 2.15e-05
299 NEGATIVE REGULATION OF GENE EXPRESSION 192 1493 1.466e-06 2.274e-05
300 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 34 154 1.462e-06 2.274e-05
301 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 29 121 1.474e-06 2.279e-05
302 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 19 61 1.483e-06 2.28e-05
303 HOMEOSTATIC PROCESS 175 1337 1.485e-06 2.28e-05
304 CELL CELL SIGNALING 111 767 1.535e-06 2.349e-05
305 REGULATION OF CYTOPLASMIC TRANSPORT 77 481 1.547e-06 2.36e-05
306 RESPONSE TO CALCIUM ION 28 115 1.59e-06 2.417e-05
307 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 49 262 1.639e-06 2.484e-05
308 NEURAL CREST CELL MIGRATION 17 51 1.829e-06 2.764e-05
309 HIPPO SIGNALING 12 27 1.848e-06 2.782e-05
310 BONE MORPHOGENESIS 22 79 1.894e-06 2.843e-05
311 EMBRYONIC ORGAN MORPHOGENESIS 51 279 2.044e-06 3.057e-05
312 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 39 191 2.054e-06 3.063e-05
313 MULTICELLULAR ORGANISMAL SIGNALING 29 123 2.106e-06 3.131e-05
314 REGULATION OF ORGAN MORPHOGENESIS 46 242 2.132e-06 3.159e-05
315 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 28 117 2.293e-06 3.387e-05
316 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 22 80 2.385e-06 3.512e-05
317 REGULATION OF PROTEIN LOCALIZATION 131 950 2.435e-06 3.575e-05
318 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 45 236 2.51e-06 3.672e-05
319 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 67 406 2.529e-06 3.689e-05
320 REGULATION OF MUSCLE ADAPTATION 19 63 2.555e-06 3.715e-05
321 SEX DIFFERENTIATION 49 266 2.567e-06 3.721e-05
322 CELL PROLIFERATION 99 672 2.586e-06 3.735e-05
323 REGULATION OF INTRACELLULAR TRANSPORT 93 621 2.593e-06 3.735e-05
324 LEUKOCYTE MIGRATION 48 259 2.717e-06 3.9e-05
325 PEPTIDYL TYROSINE MODIFICATION 38 186 2.724e-06 3.9e-05
326 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 21 75 2.93e-06 4.183e-05
327 KIDNEY EPITHELIUM DEVELOPMENT 29 125 2.979e-06 4.239e-05
328 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 9 16 3.173e-06 4.501e-05
329 DIVALENT INORGANIC CATION TRANSPORT 49 268 3.196e-06 4.52e-05
330 CELL MATRIX ADHESION 28 119 3.272e-06 4.614e-05
331 REGULATION OF PHOSPHOLIPASE ACTIVITY 19 64 3.319e-06 4.666e-05
332 CELLULAR RESPONSE TO AMINO ACID STIMULUS 17 53 3.342e-06 4.683e-05
333 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 25 100 3.397e-06 4.746e-05
334 EAR DEVELOPMENT 39 195 3.492e-06 4.865e-05
335 ACTION POTENTIAL 24 94 3.563e-06 4.937e-05
336 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 20 70 3.565e-06 4.937e-05
337 REGULATION OF PROTEIN IMPORT 37 183 4.726e-06 6.525e-05
338 CELL CHEMOTAXIS 34 162 4.829e-06 6.648e-05
339 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 16 49 4.977e-06 6.817e-05
340 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 25 102 4.981e-06 6.817e-05
341 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 42 220 5.184e-06 7.074e-05
342 REGULATION OF MESENCHYMAL CELL PROLIFERATION 13 34 5.302e-06 7.193e-05
343 CAMP METABOLIC PROCESS 13 34 5.302e-06 7.193e-05
344 REGULATION OF RESPONSE TO STRESS 186 1468 5.577e-06 7.543e-05
345 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 99 684 5.61e-06 7.566e-05
346 MEMBRANE ASSEMBLY 11 25 5.65e-06 7.598e-05
347 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 22 84 5.733e-06 7.687e-05
348 FEMALE SEX DIFFERENTIATION 27 116 6.049e-06 8.087e-05
349 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 191 1517 6.17e-06 8.179e-05
350 CELL JUNCTION ORGANIZATION 37 185 6.148e-06 8.179e-05
351 RESPONSE TO EXTRACELLULAR STIMULUS 70 441 6.158e-06 8.179e-05
352 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 16 50 6.69e-06 8.844e-05
353 EPITHELIAL CELL DEVELOPMENT 37 186 6.998e-06 9.225e-05
354 REGULATION OF ORGAN GROWTH 20 73 7.211e-06 9.478e-05
355 SPROUTING ANGIOGENESIS 15 45 7.358e-06 9.632e-05
356 NEGATIVE REGULATION OF CELL ADHESION 42 223 7.37e-06 9.632e-05
357 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 17 56 7.737e-06 0.0001006
358 RESPONSE TO MONOAMINE 13 35 7.72e-06 0.0001006
359 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 29 131 7.972e-06 0.0001033
360 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 40 209 8.084e-06 0.0001045
361 REGULATION OF MUSCLE CELL DIFFERENTIATION 32 152 8.481e-06 0.0001093
362 ODONTOGENESIS 25 105 8.641e-06 0.0001111
363 SECRETION 87 588 8.764e-06 0.0001123
364 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 19 68 8.885e-06 0.0001136
365 ARTERY MORPHOGENESIS 16 51 8.912e-06 0.0001136
366 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 37 188 9.032e-06 0.0001148
367 RESPONSE TO AMINO ACID 26 112 9.397e-06 0.0001188
368 REGULATION OF OSTEOBLAST DIFFERENTIATION 26 112 9.397e-06 0.0001188
369 PLASMA MEMBRANE ORGANIZATION 39 203 9.506e-06 0.0001199
370 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 41 218 9.759e-06 0.0001227
371 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 14 9.873e-06 0.0001235
372 CRANIOFACIAL SUTURE MORPHOGENESIS 8 14 9.873e-06 0.0001235
373 REGULATION OF WNT SIGNALING PATHWAY 53 310 9.909e-06 0.0001236
374 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 15 46 9.985e-06 0.0001242
375 MULTICELLULAR ORGANISM METABOLIC PROCESS 23 93 1.002e-05 0.0001243
376 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 90 616 1.023e-05 0.0001266
377 REGULATION OF WOUND HEALING 28 126 1.051e-05 0.0001294
378 CELLULAR RESPONSE TO EXTERNAL STIMULUS 47 264 1.049e-05 0.0001294
379 NEUROMUSCULAR JUNCTION DEVELOPMENT 13 36 1.106e-05 0.0001354
380 REGULATION OF AXONOGENESIS 34 168 1.105e-05 0.0001354
381 OVULATION CYCLE 26 113 1.114e-05 0.0001357
382 REGULATION OF SYNAPTIC PLASTICITY 30 140 1.112e-05 0.0001357
383 NEURAL CREST CELL DIFFERENTIATION 20 75 1.124e-05 0.0001366
384 RESPONSE TO BMP 23 94 1.211e-05 0.0001464
385 CELLULAR RESPONSE TO BMP STIMULUS 23 94 1.211e-05 0.0001464
386 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 33 162 1.282e-05 0.0001546
387 POSITIVE REGULATION OF ENDOCYTOSIS 26 114 1.317e-05 0.0001579
388 REGULATION OF EMBRYONIC DEVELOPMENT 26 114 1.317e-05 0.0001579
389 OSSIFICATION 45 251 1.333e-05 0.0001595
390 CARDIAC CONDUCTION 21 82 1.353e-05 0.0001614
391 REGULATION OF CELLULAR PROTEIN LOCALIZATION 82 552 1.359e-05 0.0001618
392 POSITIVE REGULATION OF HEART GROWTH 11 27 1.387e-05 0.0001646
393 VASCULAR PROCESS IN CIRCULATORY SYSTEM 33 163 1.467e-05 0.0001736
394 ADULT BEHAVIOR 29 135 1.472e-05 0.0001738
395 REGULATION OF HEART GROWTH 14 42 1.479e-05 0.0001743
396 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 32 156 1.486e-05 0.0001746
397 REGULATION OF BINDING 49 283 1.494e-05 0.0001751
398 SECRETION BY CELL 74 486 1.51e-05 0.0001766
399 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 16 53 1.541e-05 0.0001793
400 NEURON PROJECTION EXTENSION 16 53 1.541e-05 0.0001793
401 REGULATION OF MUSCLE HYPERTROPHY 13 37 1.56e-05 0.0001806
402 AXON EXTENSION 13 37 1.56e-05 0.0001806
403 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 25 109 1.729e-05 0.0001997
404 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 26 116 1.827e-05 0.0002104
405 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 8 15 1.943e-05 0.0002232
406 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 30 144 1.983e-05 0.0002272
407 REGULATION OF GLUCOSE IMPORT 17 60 2.134e-05 0.0002428
408 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 17 60 2.134e-05 0.0002428
409 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 17 60 2.134e-05 0.0002428
410 REGULATION OF RECEPTOR ACTIVITY 26 117 2.144e-05 0.0002433
411 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 13 38 2.171e-05 0.000244
412 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 13 38 2.171e-05 0.000244
413 ACTIVATION OF PROTEIN KINASE ACTIVITY 48 279 2.156e-05 0.000244
414 POSITIVE REGULATION OF ORGAN GROWTH 13 38 2.171e-05 0.000244
415 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 12 33 2.221e-05 0.000249
416 DIVALENT INORGANIC CATION HOMEOSTASIS 56 343 2.247e-05 0.0002514
417 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 31 152 2.261e-05 0.0002523
418 LOCOMOTORY BEHAVIOR 35 181 2.31e-05 0.0002571
419 REGULATION OF STRIATED MUSCLE CONTRACTION 20 79 2.584e-05 0.0002866
420 PALLIUM DEVELOPMENT 31 153 2.587e-05 0.0002866
421 CELLULAR RESPONSE TO INSULIN STIMULUS 30 146 2.619e-05 0.0002895
422 CELL FATE COMMITMENT 41 227 2.646e-05 0.0002917
423 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 37 197 2.676e-05 0.0002944
424 CEREBRAL CORTEX DEVELOPMENT 24 105 2.686e-05 0.0002948
425 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 18 67 2.733e-05 0.0002992
426 EAR MORPHOGENESIS 25 112 2.829e-05 0.000309
427 REGULATION OF PHOSPHOLIPASE C ACTIVITY 13 39 2.98e-05 0.0003232
428 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 23 99 2.976e-05 0.0003232
429 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 23 99 2.976e-05 0.0003232
430 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 39 213 2.998e-05 0.0003244
431 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 7 12 3.083e-05 0.0003304
432 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 11 29 3.089e-05 0.0003304
433 AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 12 3.083e-05 0.0003304
434 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 11 29 3.089e-05 0.0003304
435 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 63 404 3.067e-05 0.0003304
436 IMMUNE SYSTEM DEVELOPMENT 84 582 3.139e-05 0.000335
437 RESPONSE TO REACTIVE OXYGEN SPECIES 36 191 3.159e-05 0.0003364
438 CYTOSKELETON ORGANIZATION 113 838 3.24e-05 0.0003442
439 REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 9 20 3.299e-05 0.0003488
440 MELANOCYTE DIFFERENTIATION 9 20 3.299e-05 0.0003488
441 REGULATION OF STEM CELL DIFFERENTIATION 25 113 3.316e-05 0.0003499
442 FOREBRAIN CELL MIGRATION 17 62 3.406e-05 0.0003586
443 NEGATIVE REGULATION OF ION TRANSPORT 27 127 3.474e-05 0.0003649
444 NEURON CELL CELL ADHESION 8 16 3.568e-05 0.0003731
445 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 8 16 3.568e-05 0.0003731
446 EXOCRINE SYSTEM DEVELOPMENT 14 45 3.577e-05 0.0003732
447 RESPONSE TO METAL ION 54 333 3.777e-05 0.0003932
448 METANEPHROS DEVELOPMENT 20 81 3.819e-05 0.0003966
449 REGULATION OF SECRETION 97 699 3.869e-05 0.000401
450 NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 28 135 4.022e-05 0.0004159
451 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 10 25 4.153e-05 0.0004284
452 SKELETAL SYSTEM MORPHOGENESIS 37 201 4.206e-05 0.000433
453 REGULATION OF CARTILAGE DEVELOPMENT 17 63 4.265e-05 0.0004371
454 REGULATION OF COAGULATION 21 88 4.265e-05 0.0004371
455 MEMBRANE BIOGENESIS 11 30 4.469e-05 0.000457
456 NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 29 143 4.567e-05 0.000466
457 CELL JUNCTION ASSEMBLY 27 129 4.638e-05 0.0004722
458 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 19 76 4.925e-05 0.0004993
459 RENAL SYSTEM PROCESS 23 102 4.92e-05 0.0004993
460 RESPONSE TO ESTROGEN 39 218 5.117e-05 0.0005165
461 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 39 218 5.117e-05 0.0005165
462 MUSCLE ORGAN MORPHOGENESIS 18 70 5.168e-05 0.0005205
463 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 37 203 5.238e-05 0.0005264
464 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 13 41 5.417e-05 0.0005433
465 REGULATION OF LIPASE ACTIVITY 20 83 5.554e-05 0.0005546
466 RESPONSE TO FATTY ACID 20 83 5.554e-05 0.0005546
467 ACTIN FILAMENT ORGANIZATION 33 174 5.83e-05 0.0005809
468 REGULATION OF CELL MATRIX ADHESION 21 90 6.075e-05 0.000604
469 REGULATION OF VASCULOGENESIS 7 13 6.142e-05 0.0006068
470 VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 7 13 6.142e-05 0.0006068
471 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 7 13 6.142e-05 0.0006068
472 INOSITOL LIPID MEDIATED SIGNALING 26 124 6.16e-05 0.0006072
473 CYCLIC NUCLEOTIDE CATABOLIC PROCESS 8 17 6.19e-05 0.0006077
474 EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 8 17 6.19e-05 0.0006077
475 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 11 31 6.348e-05 0.0006218
476 LEUKOCYTE ACTIVATION 63 414 6.439e-05 0.0006294
477 RESPONSE TO INSULIN 37 205 6.495e-05 0.0006336
478 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 15 53 6.532e-05 0.0006345
479 NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 15 53 6.532e-05 0.0006345
480 TISSUE MIGRATION 20 84 6.661e-05 0.0006457
481 MULTI MULTICELLULAR ORGANISM PROCESS 38 213 6.748e-05 0.0006528
482 LEUKOCYTE DIFFERENTIATION 48 292 7.058e-05 0.0006813
483 REGULATION OF BLOOD PRESSURE 32 169 7.736e-05 0.0007422
484 APPENDAGE DEVELOPMENT 32 169 7.736e-05 0.0007422
485 LIMB DEVELOPMENT 32 169 7.736e-05 0.0007422
486 ION TRANSPORT 157 1262 7.947e-05 0.0007542
487 CARDIAC SEPTUM DEVELOPMENT 20 85 7.959e-05 0.0007542
488 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 14 48 7.923e-05 0.0007542
489 PALATE DEVELOPMENT 20 85 7.959e-05 0.0007542
490 DIGESTIVE TRACT MORPHOGENESIS 14 48 7.923e-05 0.0007542
491 HEART PROCESS 20 85 7.959e-05 0.0007542
492 POSITIVE REGULATION OF RESPONSE TO WOUNDING 31 162 8.098e-05 0.0007659
493 POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 12 37 8.157e-05 0.000767
494 POSITIVE REGULATION OF MUSCLE HYPERTROPHY 9 22 8.226e-05 0.000767
495 REGULATION OF NEURON APOPTOTIC PROCESS 35 192 8.214e-05 0.000767
496 SOMATIC STEM CELL DIVISION 9 22 8.226e-05 0.000767
497 REGULATION OF PROTEIN AUTOPHOSPHORYLATION 12 37 8.157e-05 0.000767
498 POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY 9 22 8.226e-05 0.000767
499 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 26 126 8.167e-05 0.000767
500 EXOCYTOSIS 50 310 8.27e-05 0.0007696
501 WNT SIGNALING PATHWAY 55 351 8.35e-05 0.0007755
502 INNER EAR MORPHOGENESIS 21 92 8.541e-05 0.0007916
503 PATTERN SPECIFICATION PROCESS 63 418 8.558e-05 0.0007917
504 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 19 79 8.686e-05 0.0008019
505 SALIVARY GLAND DEVELOPMENT 11 32 8.864e-05 0.0008151
506 REGULATION OF ACTIN FILAMENT BASED MOVEMENT 11 32 8.864e-05 0.0008151
507 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 10 27 9.011e-05 0.0008238
508 REGULATION OF CATENIN IMPORT INTO NUCLEUS 10 27 9.011e-05 0.0008238
509 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 10 27 9.011e-05 0.0008238
510 REGULATION OF FAT CELL DIFFERENTIATION 23 106 9.251e-05 0.0008423
511 CARDIAC VENTRICLE DEVELOPMENT 23 106 9.251e-05 0.0008423
512 CELLULAR RESPONSE TO KETONE 18 73 9.358e-05 0.0008504
513 REGULATION OF DENDRITE DEVELOPMENT 25 120 9.438e-05 0.000856
514 NEGATIVE REGULATION OF NEURON DEATH 32 171 9.76e-05 0.0008835
515 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 48 296 9.933e-05 0.0008975
516 AGING 44 264 0.0001002 0.0009032
517 NEPHRON EPITHELIUM DEVELOPMENT 21 93 0.0001008 0.0009071
518 CELLULAR RESPONSE TO CALCIUM ION 14 49 0.0001015 0.0009118
519 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 18 0.0001023 0.0009158
520 SMOOTH MUSCLE TISSUE DEVELOPMENT 8 18 0.0001023 0.0009158
521 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 27 135 0.0001053 0.0009405
522 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 32 172 0.0001094 0.0009734
523 REGULATION OF RENAL SYSTEM PROCESS 12 38 0.0001092 0.0009734
524 REGULATION OF ACUTE INFLAMMATORY RESPONSE 18 74 0.000113 0.0009981
525 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 7 14 0.000113 0.0009981
526 POSITIVE REGULATION OF FATTY ACID OXIDATION 7 14 0.000113 0.0009981
527 CAMP CATABOLIC PROCESS 7 14 0.000113 0.0009981
528 CELLULAR RESPONSE TO OXYGEN LEVELS 28 143 0.0001163 0.001025
529 REGULATION OF CELL JUNCTION ASSEMBLY 17 68 0.0001209 0.001062
530 HORMONE MEDIATED SIGNALING PATHWAY 30 158 0.0001212 0.001062
531 RESPONSE TO PURINE CONTAINING COMPOUND 30 158 0.0001212 0.001062
532 NEURON RECOGNITION 11 33 0.0001219 0.001066
533 REGULATION OF METANEPHROS DEVELOPMENT 9 23 0.000124 0.001081
534 TRABECULA FORMATION 9 23 0.000124 0.001081
535 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 25 122 0.0001247 0.001085
536 REGULATION OF PROTEIN TARGETING 49 307 0.000126 0.001094
537 PROTEIN LOCALIZATION TO CELL PERIPHERY 29 151 0.0001267 0.001098
538 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 16 62 0.0001269 0.001098
539 REGULATION OF FATTY ACID OXIDATION 10 28 0.0001286 0.00111
540 REGULATION OF STEM CELL PROLIFERATION 20 88 0.000133 0.001146
541 MULTI ORGANISM BEHAVIOR 18 75 0.000136 0.001169
542 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 29 152 0.0001429 0.001227
543 LONG TERM SYNAPTIC POTENTIATION 12 39 0.0001445 0.001236
544 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 12 39 0.0001445 0.001236
545 LYMPHOCYTE ACTIVATION 53 342 0.0001486 0.001268
546 NEGATIVE REGULATION OF MAPK CASCADE 28 145 0.0001491 0.001271
547 POST EMBRYONIC DEVELOPMENT 20 89 0.0001567 0.001333
548 ENDOTHELIAL CELL DEVELOPMENT 13 45 0.0001577 0.001337
549 LUNG MORPHOGENESIS 13 45 0.0001577 0.001337
550 RETINA DEVELOPMENT IN CAMERA TYPE EYE 26 131 0.0001596 0.001351
551 FIBRIL ORGANIZATION 8 19 0.0001624 0.001357
552 REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 8 19 0.0001624 0.001357
553 KIDNEY VASCULATURE DEVELOPMENT 8 19 0.0001624 0.001357
554 NEGATIVE REGULATION OF CHEMOTAXIS 14 51 0.0001628 0.001357
555 CELLULAR RESPONSE TO FATTY ACID 14 51 0.0001628 0.001357
556 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 19 0.0001624 0.001357
557 RENAL SYSTEM VASCULATURE DEVELOPMENT 8 19 0.0001624 0.001357
558 MYOTUBE DIFFERENTIATION 15 57 0.0001615 0.001357
559 FOREBRAIN NEURON DEVELOPMENT 11 34 0.0001651 0.001374
560 REGULATION OF MUSCLE TISSUE DEVELOPMENT 22 103 0.0001659 0.001377
561 NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT 24 117 0.000166 0.001377
562 REGULATION OF VESICLE MEDIATED TRANSPORT 67 462 0.0001665 0.001379
563 RESPONSE TO OXIDATIVE STRESS 54 352 0.0001685 0.001392
564 POSITIVE REGULATION OF GROWTH 40 238 0.0001689 0.001394
565 ION HOMEOSTASIS 80 576 0.0001748 0.001439
566 STEM CELL DIVISION 10 29 0.00018 0.001479
567 RESPONSE TO STARVATION 29 154 0.000181 0.001485
568 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 9 24 0.0001821 0.001487
569 BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 9 24 0.0001821 0.001487
570 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 24 0.0001821 0.001487
571 MESONEPHROS DEVELOPMENT 20 90 0.0001841 0.0015
572 STEROID HORMONE MEDIATED SIGNALING PATHWAY 25 125 0.0001866 0.001518
573 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 21 97 0.0001897 0.00154
574 REGULATION OF HEAT GENERATION 7 15 0.0001948 0.001579
575 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 69 482 0.0001977 0.001599
576 REGULATION OF CHONDROCYTE DIFFERENTIATION 13 46 0.0002013 0.001626
577 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 34 193 0.0002038 0.001644
578 REPRODUCTION 158 1297 0.0002106 0.001695
579 NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 17 71 0.0002131 0.001709
580 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 46 289 0.000213 0.001709
581 REGULATION OF PROTEIN SECRETION 58 389 0.0002143 0.001716
582 MEMORY 21 98 0.0002206 0.001763
583 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 57 381 0.0002212 0.001766
584 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 96 724 0.0002297 0.00183
585 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 15 59 0.0002446 0.001942
586 REGULATION OF MEMBRANE DEPOLARIZATION 12 41 0.0002449 0.001942
587 AORTA DEVELOPMENT 12 41 0.0002449 0.001942
588 NEGATIVE REGULATION OF CELL MATRIX ADHESION 10 30 0.0002476 0.001953
589 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 30 0.0002476 0.001953
590 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 10 30 0.0002476 0.001953
591 RELAXATION OF MUSCLE 8 20 0.0002487 0.001955
592 POSITIVE REGULATION OF CHEMOTAXIS 24 120 0.0002486 0.001955
593 REGULATION OF AMINE TRANSPORT 17 72 0.0002551 0.002002
594 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 22 106 0.0002562 0.002003
595 LIPID PHOSPHORYLATION 21 99 0.0002558 0.002003
596 REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 9 25 0.0002612 0.002036
597 POSTSYNAPTIC MEMBRANE ORGANIZATION 9 25 0.0002612 0.002036
598 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 26 135 0.0002639 0.002054
599 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 16 66 0.0002781 0.00215
600 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 16 66 0.0002781 0.00215
601 POSITIVE REGULATION OF LIPASE ACTIVITY 16 66 0.0002781 0.00215
602 LENS DEVELOPMENT IN CAMERA TYPE EYE 16 66 0.0002781 0.00215
603 POSITIVE REGULATION OF CELL ADHESION 56 376 0.0002807 0.002166
604 NEGATIVE REGULATION OF CELL ACTIVATION 29 158 0.0002852 0.002197
605 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 53 351 0.0002871 0.002205
606 REGULATION OF NEURON DEATH 41 252 0.0002869 0.002205
607 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 11 36 0.0002913 0.002229
608 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 11 36 0.0002913 0.002229
609 REGULATION OF SMOOTH MUSCLE CONTRACTION 15 60 0.0002984 0.002261
610 STEM CELL PROLIFERATION 15 60 0.0002984 0.002261
611 CHONDROCYTE DIFFERENTIATION 15 60 0.0002984 0.002261
612 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 15 60 0.0002984 0.002261
613 GLIAL CELL DIFFERENTIATION 26 136 0.000298 0.002261
614 EYE MORPHOGENESIS 26 136 0.000298 0.002261
615 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 53 352 0.0003082 0.002331
616 POSITIVE REGULATION OF GLUCOSE TRANSPORT 12 42 0.0003142 0.002373
617 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 16 0.0003186 0.002387
618 REGULATION OF JNK CASCADE 29 159 0.0003184 0.002387
619 RESPONSE TO EPINEPHRINE 7 16 0.0003186 0.002387
620 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 7 16 0.0003186 0.002387
621 BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 7 16 0.0003186 0.002387
622 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 13 48 0.0003201 0.002394
623 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 23 115 0.0003314 0.002475
624 CELLULAR CHEMICAL HOMEOSTASIS 78 570 0.000333 0.002483
625 REGULATION OF EXTENT OF CELL GROWTH 21 101 0.0003413 0.002541
626 GLIOGENESIS 31 175 0.0003441 0.002558
627 REGULATION OF CELLULAR COMPONENT SIZE 51 337 0.0003506 0.002602
628 MEMBRANE DEPOLARIZATION 15 61 0.0003622 0.002658
629 ROUNDABOUT SIGNALING PATHWAY 6 12 0.0003608 0.002658
630 GLUCOSE IMPORT 6 12 0.0003608 0.002658
631 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 6 12 0.0003608 0.002658
632 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 15 61 0.0003622 0.002658
633 POSITIVE REGULATION OF STEM CELL PROLIFERATION 15 61 0.0003622 0.002658
634 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 6 12 0.0003608 0.002658
635 VASODILATION 9 26 0.0003668 0.002675
636 GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 9 26 0.0003668 0.002675
637 MESODERMAL CELL DIFFERENTIATION 9 26 0.0003668 0.002675
638 HEART GROWTH 9 26 0.0003668 0.002675
639 REGULATION OF ENDOCYTOSIS 34 199 0.0003677 0.002678
640 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 8 21 0.0003691 0.002684
641 POSITIVE REGULATION OF MAP KINASE ACTIVITY 35 207 0.0003721 0.002701
642 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 28 153 0.0003781 0.00274
643 MATING 11 37 0.0003801 0.002746
644 CARDIAC MUSCLE CELL ACTION POTENTIAL 11 37 0.0003801 0.002746
645 REGULATION OF KIDNEY DEVELOPMENT 14 55 0.000385 0.002769
646 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 14 55 0.000385 0.002769
647 CRANIAL SKELETAL SYSTEM DEVELOPMENT 14 55 0.000385 0.002769
648 REGULATION OF CYTOSKELETON ORGANIZATION 70 502 0.0003857 0.002769
649 CELLULAR RESPONSE TO OXIDATIVE STRESS 32 184 0.0003909 0.002803
650 REGENERATION 29 161 0.0003953 0.002816
651 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 20 95 0.0003942 0.002816
652 SYNAPTIC SIGNALING 61 424 0.000395 0.002816
653 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 20 95 0.0003942 0.002816
654 LIPID LOCALIZATION 42 264 0.0003959 0.002817
655 PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 13 49 0.000399 0.00283
656 CARDIAC SEPTUM MORPHOGENESIS 13 49 0.000399 0.00283
657 AMINOGLYCAN CATABOLIC PROCESS 16 68 0.0003999 0.002832
658 RESPONSE TO ESTRADIOL 27 146 0.0004014 0.002836
659 VESICLE MEDIATED TRANSPORT 150 1239 0.0004017 0.002836
660 NEGATIVE REGULATION OF SECRETION 34 200 0.0004043 0.00285
661 CARDIAC VENTRICLE MORPHOGENESIS 15 62 0.0004372 0.003078
662 DEVELOPMENTAL MATURATION 33 193 0.0004388 0.003084
663 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 29 162 0.0004395 0.003085
664 FORMATION OF PRIMARY GERM LAYER 22 110 0.000442 0.003097
665 ENDOCARDIAL CUSHION DEVELOPMENT 10 32 0.0004473 0.003121
666 ADIPOSE TISSUE DEVELOPMENT 10 32 0.0004473 0.003121
667 LYMPHOCYTE DIFFERENTIATION 35 209 0.0004473 0.003121
668 REGULATION OF MUSCLE ORGAN DEVELOPMENT 21 103 0.0004509 0.003141
669 GLUCOSE HOMEOSTASIS 30 170 0.0004542 0.003154
670 CARBOHYDRATE HOMEOSTASIS 30 170 0.0004542 0.003154
671 LIPID METABOLIC PROCESS 141 1158 0.0004692 0.003253
672 SMAD PROTEIN SIGNAL TRANSDUCTION 14 56 0.0004699 0.003254
673 POSITIVE REGULATION OF AXONOGENESIS 16 69 0.0004764 0.003289
674 RESPONSE TO ACTIVITY 16 69 0.0004764 0.003289
675 CELLULAR HOMEOSTASIS 89 676 0.0004832 0.003331
676 REGULATION OF ACTION POTENTIAL 11 38 0.0004904 0.003376
677 REGULATION OF ADHERENS JUNCTION ORGANIZATION 13 50 0.0004938 0.003384
678 CELLULAR RESPONSE TO CAMP 13 50 0.0004938 0.003384
679 VISUAL BEHAVIOR 13 50 0.0004938 0.003384
680 NEGATIVE REGULATION OF PLATELET ACTIVATION 7 17 0.0004983 0.003405
681 REGULATION OF PROTEIN KINASE A SIGNALING 7 17 0.0004983 0.003405
682 REGULATION OF CALCIUM MEDIATED SIGNALING 17 76 0.0005032 0.003418
683 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 12 44 0.0005031 0.003418
684 NEGATIVE REGULATION OF JAK STAT CASCADE 12 44 0.0005031 0.003418
685 NEGATIVE REGULATION OF STAT CASCADE 12 44 0.0005031 0.003418
686 RESPONSE TO CAMP 21 104 0.0005163 0.003497
687 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 21 104 0.0005163 0.003497
688 REGULATION OF POTASSIUM ION TRANSPORT 18 83 0.0005191 0.00351
689 BONE CELL DEVELOPMENT 8 22 0.000533 0.003595
690 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 8 22 0.000533 0.003595
691 INTERACTION WITH HOST 25 134 0.0005643 0.0038
692 ENDOTHELIAL CELL MIGRATION 14 57 0.0005704 0.003835
693 POSITIVE REGULATION OF SECRETION 54 370 0.0005866 0.003939
694 POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 10 33 0.0005889 0.003948
695 REGULATION OF BMP SIGNALING PATHWAY 17 77 0.0005907 0.003955
696 POSITIVE REGULATION OF BINDING 24 127 0.0005948 0.003976
697 RELAXATION OF CARDIAC MUSCLE 6 13 0.0006175 0.00411
698 REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 6 13 0.0006175 0.00411
699 EXTRACELLULAR FIBRIL ORGANIZATION 6 13 0.0006175 0.00411
700 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 11 39 0.0006263 0.004145
701 METAL ION TRANSPORT 78 582 0.0006249 0.004145
702 REGULATION OF AXON GUIDANCE 11 39 0.0006263 0.004145
703 TRABECULA MORPHOGENESIS 11 39 0.0006263 0.004145
704 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 12 45 0.0006287 0.004155
705 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 57 397 0.0006326 0.004175
706 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 54 372 0.0006675 0.0044
707 REGULATION OF GLUCOSE METABOLIC PROCESS 21 106 0.0006723 0.004425
708 VENTRICULAR SEPTUM MORPHOGENESIS 9 28 0.0006835 0.004485
709 RIBONUCLEOTIDE CATABOLIC PROCESS 9 28 0.0006835 0.004485
710 NEGATIVE REGULATION OF WOUND HEALING 14 58 0.0006884 0.004512
711 RENAL TUBULE DEVELOPMENT 17 78 0.000691 0.004522
712 CALCIUM ION TRANSMEMBRANE TRANSPORT 28 159 0.000715 0.004672
713 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 15 65 0.0007471 0.004876
714 REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 8 23 0.0007512 0.004882
715 STRIATED MUSCLE ADAPTATION 8 23 0.0007512 0.004882
716 INNERVATION 8 23 0.0007512 0.004882
717 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 34 0.0007654 0.004953
718 RESPONSE TO FLUID SHEAR STRESS 10 34 0.0007654 0.004953
719 RESPONSE TO PROSTAGLANDIN 10 34 0.0007654 0.004953
720 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 20 100 0.0007879 0.005092
721 SKELETAL MUSCLE ORGAN DEVELOPMENT 25 137 0.000791 0.005098
722 DEVELOPMENTAL PIGMENTATION 11 40 0.0007921 0.005098
723 REGULATION OF FILOPODIUM ASSEMBLY 11 40 0.0007921 0.005098
724 REGULATION OF DNA BINDING 19 93 0.0008041 0.005168
725 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 26 145 0.0008249 0.005294
726 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 14 59 0.0008265 0.005297
727 REGULATION OF LIPID METABOLIC PROCESS 43 282 0.0008371 0.005358
728 NEGATIVE REGULATION OF PROTEIN SECRETION 21 108 0.0008675 0.005545
729 MESODERM MORPHOGENESIS 15 66 0.0008851 0.005642
730 REGULATION OF VASOCONSTRICTION 15 66 0.0008851 0.005642
731 CAMERA TYPE EYE MORPHOGENESIS 20 101 0.0008982 0.005717
732 NEGATIVE REGULATION OF RECEPTOR ACTIVITY 9 29 0.00091 0.005769
733 PIGMENT CELL DIFFERENTIATION 9 29 0.00091 0.005769
734 CARDIAC MUSCLE CELL CONTRACTION 9 29 0.00091 0.005769
735 ASSOCIATIVE LEARNING 16 73 0.0009203 0.005826
736 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 18 87 0.000935 0.005911
737 POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 12 47 0.0009595 0.006058
738 LIPID MODIFICATION 34 210 0.0009887 0.006162
739 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 6 14 0.0009959 0.006162
740 RESPONSE TO ORGANOPHOSPHORUS 25 139 0.0009828 0.006162
741 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 11 41 0.0009928 0.006162
742 NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 10 35 0.0009833 0.006162
743 EPITHELIAL CELL CELL ADHESION 6 14 0.0009959 0.006162
744 GOLGI TO PLASMA MEMBRANE TRANSPORT 11 41 0.0009928 0.006162
745 VOCALIZATION BEHAVIOR 6 14 0.0009959 0.006162
746 REGULATION OF GLOMERULUS DEVELOPMENT 6 14 0.0009959 0.006162
747 REGULATION OF GASTRULATION 10 35 0.0009833 0.006162
748 POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 6 14 0.0009959 0.006162
749 CELL SUBSTRATE JUNCTION ASSEMBLY 11 41 0.0009928 0.006162
750 REGULATION OF CELL SHAPE 25 139 0.0009828 0.006162
751 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 6 14 0.0009959 0.006162
752 RESPONSE TO LAMINAR FLUID SHEAR STRESS 6 14 0.0009959 0.006162
753 EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 8 24 0.001036 0.0064
754 LEUKOCYTE CHEMOTAXIS 22 117 0.001056 0.006514
755 REGULATION OF DENDRITE MORPHOGENESIS 16 74 0.001075 0.006622
756 CARDIAC MUSCLE TISSUE MORPHOGENESIS 13 54 0.001086 0.006684
757 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 7 19 0.001093 0.006702
758 GLOMERULAR EPITHELIUM DEVELOPMENT 7 19 0.001093 0.006702
759 REGULATION OF LONG TERM SYNAPTIC POTENTIATION 7 19 0.001093 0.006702
760 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 21 110 0.00111 0.006794
761 CATION TRANSPORT 100 796 0.001124 0.006873
762 MALE SEX DIFFERENTIATION 26 148 0.001127 0.006883
763 REGULATION OF CIRCADIAN RHYTHM 20 103 0.001159 0.007067
764 RESPONSE TO AXON INJURY 12 48 0.001173 0.007123
765 REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 12 48 0.001173 0.007123
766 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 12 48 0.001173 0.007123
767 REGULATION OF HORMONE LEVELS 65 478 0.001178 0.007148
768 REGULATION OF CELL SIZE 29 172 0.001185 0.007166
769 MESODERM DEVELOPMENT 22 118 0.001186 0.007166
770 G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 29 172 0.001185 0.007166
771 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 9 30 0.001194 0.007196
772 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 9 30 0.001194 0.007196
773 IMMUNE SYSTEM PROCESS 223 1984 0.001211 0.007287
774 ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 15 68 0.001226 0.007372
775 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 11 42 0.001234 0.007387
776 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 11 42 0.001234 0.007387
777 NEGATIVE REGULATION OF GTPASE ACTIVITY 11 42 0.001234 0.007387
778 REGULATION OF LEUKOCYTE MIGRATION 26 149 0.001247 0.007432
779 OLFACTORY LOBE DEVELOPMENT 10 36 0.001249 0.007432
780 BIOMINERAL TISSUE DEVELOPMENT 16 75 0.00125 0.007432
781 KIDNEY MORPHOGENESIS 17 82 0.001251 0.007432
782 INTEGRIN MEDIATED SIGNALING PATHWAY 17 82 0.001251 0.007432
783 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 10 36 0.001249 0.007432
784 ALCOHOL METABOLIC PROCESS 50 348 0.001296 0.007681
785 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 32 197 0.001296 0.007681
786 CELLULAR LIPID METABOLIC PROCESS 112 913 0.001356 0.008028
787 EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 8 25 0.0014 0.008257
788 CELLULAR EXTRAVASATION 8 25 0.0014 0.008257
789 DOPAMINE METABOLIC PROCESS 8 25 0.0014 0.008257
790 ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 18 90 0.00141 0.008302
791 CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 29 174 0.001424 0.008368
792 NEGATIVE REGULATION OF PEPTIDE SECRETION 12 49 0.001424 0.008368
793 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 15 69 0.001435 0.008417
794 PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 17 83 0.001439 0.008433
795 ENDOCYTOSIS 68 509 0.001464 0.008566
796 CYTOKINE PRODUCTION 22 120 0.001488 0.008699
797 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 15 0.00153 0.008909
798 REGULATION OF N METHYL D ASPARTATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 6 15 0.00153 0.008909
799 VENOUS BLOOD VESSEL DEVELOPMENT 6 15 0.00153 0.008909
800 REFLEX 7 20 0.001548 0.008981
801 TRACHEA DEVELOPMENT 7 20 0.001548 0.008981
802 REGULATION OF PLATELET ACTIVATION 9 31 0.001545 0.008981
803 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 23 128 0.001554 0.009007
804 CORONARY VASCULATURE DEVELOPMENT 10 37 0.001571 0.00905
805 ACTIN POLYMERIZATION OR DEPOLYMERIZATION 10 37 0.001571 0.00905
806 REGULATION OF MEMBRANE LIPID DISTRIBUTION 10 37 0.001571 0.00905
807 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 10 37 0.001571 0.00905
808 CAMP MEDIATED SIGNALING 10 37 0.001571 0.00905
809 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 21 113 0.001581 0.00909
810 REGULATION OF CELL ACTIVATION 65 484 0.001614 0.00927
811 REGULATION OF JAK STAT CASCADE 25 144 0.001647 0.009439
812 REGULATION OF STAT CASCADE 25 144 0.001647 0.009439
813 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 17 84 0.001651 0.009448
814 NEGATIVE REGULATION OF IMMUNE RESPONSE 22 121 0.001663 0.009504
815 NEURAL PRECURSOR CELL PROLIFERATION 15 70 0.001672 0.009544
816 ACTOMYOSIN STRUCTURE ORGANIZATION 16 77 0.001674 0.009548
817 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 12 50 0.001717 0.009756
818 MULTI ORGANISM REPRODUCTIVE PROCESS 109 891 0.001714 0.009756
819 PURINE CONTAINING COMPOUND CATABOLIC PROCESS 12 50 0.001717 0.009756
820 REGULATION OF REPRODUCTIVE PROCESS 23 129 0.001729 0.00981
821 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 19 99 0.001754 0.00994
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 235 1476 2.452e-17 2.278e-14
2 CYTOSKELETAL PROTEIN BINDING 146 819 5.636e-15 1.745e-12
3 GROWTH FACTOR BINDING 43 123 4.525e-15 1.745e-12
4 GLYCOSAMINOGLYCAN BINDING 57 205 1.92e-14 4.46e-12
5 ACTIN BINDING 85 393 8.915e-14 1.656e-11
6 SULFUR COMPOUND BINDING 60 234 2.04e-13 3.158e-11
7 HEPARIN BINDING 46 157 8.164e-13 9.483e-11
8 CELL ADHESION MOLECULE BINDING 51 186 8.166e-13 9.483e-11
9 MOLECULAR FUNCTION REGULATOR 201 1353 6.084e-12 5.652e-10
10 ENZYME BINDING 245 1737 6.032e-12 5.652e-10
11 CALCIUM ION BINDING 120 697 1.801e-11 1.521e-09
12 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 54 228 8.695e-11 6.731e-09
13 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 108 629 2.238e-10 1.6e-08
14 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 28 81 3.548e-10 2.354e-08
15 MACROMOLECULAR COMPLEX BINDING 197 1399 1.074e-09 6.651e-08
16 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 65 328 3.332e-09 1.934e-07
17 PROTEIN COMPLEX BINDING 140 935 7.502e-09 4.1e-07
18 CYTOKINE BINDING 28 92 9.306e-09 4.803e-07
19 TRANSFORMING GROWTH FACTOR BETA BINDING 11 16 1.223e-08 5.978e-07
20 KINASE ACTIVITY 128 842 1.371e-08 6.331e-07
21 INTEGRIN BINDING 30 105 1.431e-08 6.331e-07
22 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 59 303 3.391e-08 1.432e-06
23 PROTEIN DOMAIN SPECIFIC BINDING 100 624 4.115e-08 1.662e-06
24 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 60 315 5.945e-08 2.301e-06
25 KINASE BINDING 97 606 6.976e-08 2.592e-06
26 IDENTICAL PROTEIN BINDING 166 1209 1.376e-07 4.917e-06
27 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 21 64 1.558e-07 5.362e-06
28 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 46 226 2.852e-07 9.463e-06
29 SMAD BINDING 22 72 3.27e-07 1.048e-05
30 PROTEIN KINASE ACTIVITY 98 640 5.048e-07 1.563e-05
31 PROTEIN DIMERIZATION ACTIVITY 156 1149 6.693e-07 2.006e-05
32 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 22 76 9.211e-07 2.674e-05
33 COLLAGEN BINDING 20 65 9.824e-07 2.766e-05
34 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 58 329 1.421e-06 3.883e-05
35 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 136 992 2.132e-06 5.658e-05
36 PROTEIN HOMODIMERIZATION ACTIVITY 105 722 2.352e-06 6.05e-05
37 ION CHANNEL BINDING 27 111 2.475e-06 6.05e-05
38 ENZYME REGULATOR ACTIVITY 132 959 2.452e-06 6.05e-05
39 PROTEIN KINASE A BINDING 15 42 2.754e-06 6.395e-05
40 CALMODULIN BINDING 37 179 2.747e-06 6.395e-05
41 SIGNAL TRANSDUCER ACTIVITY 215 1731 3.94e-06 8.716e-05
42 STEROID HORMONE RECEPTOR ACTIVITY 18 59 3.887e-06 8.716e-05
43 SULFURIC ESTER HYDROLASE ACTIVITY 9 17 6.184e-06 0.0001336
44 PROTEIN TYROSINE KINASE ACTIVITY 35 176 1.233e-05 0.0002603
45 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 19 70 1.405e-05 0.0002837
46 PLATELET DERIVED GROWTH FACTOR BINDING 7 11 1.397e-05 0.0002837
47 HORMONE BINDING 18 65 1.74e-05 0.000344
48 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 8 15 1.943e-05 0.000376
49 BINDING BRIDGING 34 173 2.113e-05 0.0004006
50 TRANSITION METAL ION BINDING 175 1400 2.342e-05 0.0004352
51 ARYLSULFATASE ACTIVITY 7 12 3.083e-05 0.0005616
52 CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 10 25 4.153e-05 0.0007419
53 ZINC ION BINDING 147 1155 4.489e-05 0.0007868
54 REGULATORY REGION NUCLEIC ACID BINDING 110 818 4.618e-05 0.0007945
55 ENZYME ACTIVATOR ACTIVITY 70 471 5.586e-05 0.0009436
56 PHOSPHORIC DIESTER HYDROLASE ACTIVITY 21 90 6.075e-05 0.0009731
57 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 21 90 6.075e-05 0.0009731
58 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 19 77 5.975e-05 0.0009731
59 LIPID BINDING 91 657 7.134e-05 0.001123
60 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 150 1199 8.775e-05 0.001359
61 CORECEPTOR ACTIVITY 12 38 0.0001092 0.001663
62 NEUREXIN FAMILY PROTEIN BINDING 7 14 0.000113 0.001693
63 PROTEIN COMPLEX SCAFFOLD 17 68 0.0001209 0.001783
64 FIBRONECTIN BINDING 10 28 0.0001286 0.001837
65 HISTONE ACETYLTRANSFERASE BINDING 10 28 0.0001286 0.001837
66 GROWTH FACTOR ACTIVITY 30 160 0.0001531 0.002155
67 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 31 168 0.0001623 0.002219
68 NITRIC OXIDE SYNTHASE BINDING 8 19 0.0001624 0.002219
69 ACTININ BINDING 10 29 0.00018 0.002423
70 RECEPTOR ACTIVITY 195 1649 0.0002003 0.002658
71 BETA CATENIN BINDING 19 84 0.0002071 0.00271
72 TRANSCRIPTION FACTOR BINDING 73 524 0.0003008 0.003881
73 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 13 48 0.0003201 0.004018
74 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 7 16 0.0003186 0.004018
75 SIGNALING ADAPTOR ACTIVITY 17 74 0.0003611 0.004473
76 SH3 DOMAIN BINDING 23 116 0.0003776 0.004615
77 CHANNEL REGULATOR ACTIVITY 25 131 0.0003966 0.004756
78 X1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 43 0.0003993 0.004756
79 INSULIN RECEPTOR BINDING 10 32 0.0004473 0.005261
80 KINASE INHIBITOR ACTIVITY 19 89 0.0004534 0.005265
81 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 25 133 0.0005026 0.005643
82 PHOSPHORIC ESTER HYDROLASE ACTIVITY 54 368 0.0005145 0.005643
83 CHEMOREPELLENT ACTIVITY 9 27 0.0005051 0.005643
84 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 7 17 0.0004983 0.005643
85 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 21 104 0.0005163 0.005643
86 RECEPTOR SIGNALING PROTEIN ACTIVITY 30 172 0.000556 0.006006
87 EXTRACELLULAR MATRIX BINDING 13 51 0.0006071 0.006409
88 PHOSPHATIDYLINOSITOL KINASE ACTIVITY 13 51 0.0006071 0.006409
89 CORE PROMOTER PROXIMAL REGION DNA BINDING 54 371 0.0006259 0.006533
90 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 128 0.0006687 0.006903
91 RHO GTPASE BINDING 17 78 0.000691 0.007054
92 GROWTH FACTOR RECEPTOR BINDING 24 129 0.0007506 0.007579
93 DOUBLE STRANDED DNA BINDING 97 764 0.0009427 0.009416
94 ENZYME INHIBITOR ACTIVITY 54 378 0.0009734 0.009519
95 G PROTEIN COUPLED RECEPTOR BINDING 40 259 0.0009715 0.009519
96 GLUCOCORTICOID RECEPTOR BINDING 6 14 0.0009959 0.009637
97 TRANSCRIPTION COFACTOR BINDING 8 24 0.001036 0.009919
NumGOOverlapSizeP ValueAdj. P Value
1 EXTRACELLULAR MATRIX 110 426 8.545e-24 4.99e-21
2 CELL PROJECTION 292 1786 2.221e-23 6.485e-21
3 PROTEINACEOUS EXTRACELLULAR MATRIX 97 356 5.99e-23 1.166e-20
4 CELL JUNCTION 205 1151 1.079e-20 1.26e-18
5 MEMBRANE REGION 203 1134 9.272e-21 1.26e-18
6 NEURON PROJECTION 175 942 1.161e-19 1.13e-17
7 SYNAPSE 148 754 5.767e-19 4.812e-17
8 NEURON PART 209 1265 3.098e-17 2.261e-15
9 EXTRACELLULAR MATRIX COMPONENT 46 125 5.076e-17 3.294e-15
10 CELL LEADING EDGE 81 350 6.858e-15 4.005e-13
11 INTRINSIC COMPONENT OF PLASMA MEMBRANE 246 1649 1.084e-14 5.753e-13
12 PLASMA MEMBRANE REGION 159 929 1.275e-14 6.207e-13
13 POSTSYNAPSE 84 378 2.526e-14 1.135e-12
14 MEMBRANE MICRODOMAIN 70 288 3.658e-14 1.526e-12
15 ANCHORING JUNCTION 97 489 4.25e-13 1.655e-11
16 CELL SUBSTRATE JUNCTION 83 398 1.388e-12 5.066e-11
17 SYNAPSE PART 111 610 3.096e-12 1.063e-10
18 DENDRITE 89 451 5.381e-12 1.746e-10
19 BASEMENT MEMBRANE 32 93 2.283e-11 7.017e-10
20 EXCITATORY SYNAPSE 50 197 3.056e-11 8.924e-10
21 I BAND 37 121 3.478e-11 9.673e-10
22 SOMATODENDRITIC COMPARTMENT 112 650 8.253e-11 2.191e-09
23 ACTIN CYTOSKELETON 84 444 1.979e-10 5.025e-09
24 CELL SURFACE 124 757 2.307e-10 5.615e-09
25 LAMELLIPODIUM 44 172 3.511e-10 8.202e-09
26 CONTRACTILE FIBER 50 211 4.217e-10 9.472e-09
27 COMPLEX OF COLLAGEN TRIMERS 14 23 1.25e-09 2.704e-08
28 SARCOLEMMA 35 125 1.665e-09 3.474e-08
29 CELL CELL JUNCTION 73 383 2.183e-09 4.396e-08
30 COLLAGEN TRIMER 28 88 3.059e-09 5.955e-08
31 PLASMA MEMBRANE PROTEIN COMPLEX 89 510 3.942e-09 7.426e-08
32 SYNAPTIC MEMBRANE 54 261 1.516e-08 2.768e-07
33 AXON 75 418 1.999e-08 3.538e-07
34 EXTRACELLULAR SPACE 188 1376 2.74e-08 4.706e-07
35 PLASMA MEMBRANE RAFT 26 86 3.636e-08 6.068e-07
36 ENDOPLASMIC RETICULUM LUMEN 44 201 5.801e-08 9.411e-07
37 CELL PROJECTION PART 137 946 8.551e-08 1.35e-06
38 PLATELET ALPHA GRANULE 23 75 1.649e-07 2.534e-06
39 POSTSYNAPTIC MEMBRANE 43 205 2.898e-07 4.34e-06
40 EXTRINSIC COMPONENT OF MEMBRANE 49 252 5.022e-07 7.332e-06
41 CELL CELL CONTACT ZONE 20 64 7.448e-07 1.012e-05
42 CYTOPLASMIC SIDE OF MEMBRANE 37 170 7.433e-07 1.012e-05
43 INTRACELLULAR VESICLE 168 1259 7.389e-07 1.012e-05
44 FILOPODIUM 25 94 9.933e-07 1.318e-05
45 CYTOSKELETON 243 1967 1.289e-06 1.673e-05
46 INTERCALATED DISC 17 51 1.829e-06 2.323e-05
47 SITE OF POLARIZED GROWTH 33 149 1.927e-06 2.394e-05
48 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 31 136 2.054e-06 2.499e-05
49 EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 25 98 2.286e-06 2.725e-05
50 NEURONAL POSTSYNAPTIC DENSITY 17 53 3.342e-06 3.903e-05
51 SIDE OF MEMBRANE 69 428 4.158e-06 4.762e-05
52 A BAND 13 34 5.302e-06 5.955e-05
53 GLYCOPROTEIN COMPLEX 10 21 6.345e-06 6.991e-05
54 GOLGI APPARATUS 183 1445 6.868e-06 7.428e-05
55 T TUBULE 15 45 7.358e-06 7.813e-05
56 RECEPTOR COMPLEX 55 327 1.11e-05 0.0001137
57 AXON PART 41 219 1.095e-05 0.0001137
58 LEADING EDGE MEMBRANE 29 134 1.266e-05 0.0001275
59 APICAL JUNCTION COMPLEX 28 128 1.438e-05 0.0001423
60 ACTIN BASED CELL PROJECTION 35 181 2.31e-05 0.0002248
61 PLATELET ALPHA GRANULE LUMEN 16 55 2.583e-05 0.0002472
62 CELL CORTEX 42 238 3.743e-05 0.0003526
63 RUFFLE 31 156 3.837e-05 0.0003557
64 SECRETORY GRANULE 56 352 4.73e-05 0.0004316
65 SECRETORY VESICLE 69 461 5.032e-05 0.0004521
66 M BAND 9 21 5.297e-05 0.0004626
67 CORTICAL ACTIN CYTOSKELETON 16 58 5.308e-05 0.0004626
68 CELL PROJECTION MEMBRANE 49 298 5.922e-05 0.0005086
69 SECRETORY GRANULE LUMEN 20 85 7.959e-05 0.0006736
70 INTERSTITIAL MATRIX 7 14 0.000113 0.0009425
71 CELL BODY 71 494 0.0001425 0.001172
72 CATION CHANNEL COMPLEX 31 167 0.000145 0.001177
73 CYTOPLASMIC REGION 46 287 0.000181 0.001438
74 VACUOLE 146 1180 0.0001822 0.001438
75 NEURON SPINE 24 121 0.0002832 0.002205
76 NEURON PROJECTION TERMINUS 25 129 0.0003107 0.002378
77 CELL CELL ADHERENS JUNCTION 14 54 0.0003135 0.002378
78 BANDED COLLAGEN FIBRIL 6 12 0.0003608 0.002702
79 BASAL LAMINA 8 21 0.0003691 0.002729
80 CORTICAL CYTOSKELETON 18 81 0.0003794 0.00277
81 ENDOPLASMIC RETICULUM 191 1631 0.0003871 0.002791
82 SARCOPLASM 16 68 0.0003999 0.002848
83 CYTOPLASMIC VESICLE PART 81 601 0.0004172 0.002936
84 ACTOMYOSIN 15 62 0.0004372 0.00304
85 CELL CORTEX PART 23 119 0.0005518 0.003791
86 ACTIN FILAMENT 16 70 0.000565 0.003837
87 VESICLE LUMEN 21 106 0.0006723 0.004513
88 RUFFLE MEMBRANE 17 80 0.0009357 0.00621
89 APICAL PART OF CELL 52 361 0.0009912 0.006462
90 FIBRIL 6 14 0.0009959 0.006462
91 MEMBRANE PROTEIN COMPLEX 124 1020 0.001077 0.006914
92 COSTAMERE 7 19 0.001093 0.00694
93 TRANSPORTER COMPLEX 47 321 0.001198 0.007525
94 PERINUCLEAR REGION OF CYTOPLASM 83 642 0.001266 0.007866
95 AXONAL GROWTH CONE 7 20 0.001548 0.009516

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 hsa04510_Focal_adhesion 58 200 1.442e-15 2.595e-13
2 hsa04512_ECM.receptor_interaction 30 85 4.618e-11 4.156e-09
3 hsa04151_PI3K_AKT_signaling_pathway 70 351 6.268e-10 3.761e-08
4 hsa04014_Ras_signaling_pathway 50 236 2.299e-08 1.034e-06
5 hsa04020_Calcium_signaling_pathway 41 177 3.073e-08 1.106e-06
6 hsa04270_Vascular_smooth_muscle_contraction 31 116 4.615e-08 1.384e-06
7 hsa04810_Regulation_of_actin_cytoskeleton 45 214 1.435e-07 3.689e-06
8 hsa04390_Hippo_signaling_pathway 34 154 1.462e-06 3.29e-05
9 hsa04350_TGF.beta_signaling_pathway 23 85 1.925e-06 3.851e-05
10 hsa04360_Axon_guidance 30 130 2.277e-06 4.098e-05
11 hsa04916_Melanogenesis 25 101 4.12e-06 6.742e-05
12 hsa04010_MAPK_signaling_pathway 48 268 7.18e-06 0.0001077
13 hsa04971_Gastric_acid_secretion 20 74 9.026e-06 0.000125
14 hsa04974_Protein_digestion_and_absorption 20 81 3.819e-05 0.000491
15 hsa04970_Salivary_secretion 21 89 5.099e-05 0.0006119
16 hsa04910_Insulin_signaling_pathway 28 138 6.071e-05 0.0006433
17 hsa04540_Gap_junction 21 90 6.075e-05 0.0006433
18 hsa04070_Phosphatidylinositol_signaling_system 19 78 7.219e-05 0.0007219
19 hsa04514_Cell_adhesion_molecules_.CAMs. 27 136 0.0001199 0.001136
20 hsa04310_Wnt_signaling_pathway 28 151 0.0003024 0.002693
21 hsa04960_Aldosterone.regulated_sodium_reabsorption 12 42 0.0003142 0.002693
22 hsa04730_Long.term_depression 16 70 0.000565 0.004623
23 hsa04520_Adherens_junction 16 73 0.0009203 0.007202
24 hsa04670_Leukocyte_transendothelial_migration 22 117 0.001056 0.007917
25 hsa04920_Adipocytokine_signaling_pathway 15 68 0.001226 0.008829
26 hsa04722_Neurotrophin_signaling_pathway 23 127 0.001395 0.009659
27 hsa04720_Long.term_potentiation 15 70 0.001672 0.01114
28 hsa04972_Pancreatic_secretion 19 101 0.002231 0.01434
29 hsa04640_Hematopoietic_cell_lineage 17 88 0.002779 0.01725
30 hsa04610_Complement_and_coagulation_cascades 14 69 0.003996 0.02398
31 hsa04630_Jak.STAT_signaling_pathway 25 155 0.004545 0.02639
32 hsa00640_Propanoate_metabolism 8 32 0.007581 0.04265
33 hsa04912_GnRH_signaling_pathway 17 101 0.01151 0.06111
34 hsa00350_Tyrosine_metabolism 9 41 0.01154 0.06111
35 hsa00120_Primary_bile_acid_biosynthesis 5 16 0.01259 0.06477
36 hsa04664_Fc_epsilon_RI_signaling_pathway 14 79 0.01347 0.0669
37 hsa04012_ErbB_signaling_pathway 15 87 0.01375 0.0669
38 hsa04380_Osteoclast_differentiation 20 128 0.01451 0.06774
39 hsa00562_Inositol_phosphate_metabolism 11 57 0.01468 0.06774
40 hsa04710_Circadian_rhythm_._mammal 6 23 0.01618 0.07282
41 hsa04662_B_cell_receptor_signaling_pathway 13 75 0.02006 0.08806
42 hsa04320_Dorso.ventral_axis_formation 6 25 0.0242 0.1017
43 hsa00300_Lysine_biosynthesis 2 3 0.0243 0.1017
44 hsa00230_Purine_metabolism 23 162 0.02668 0.1092
45 hsa00982_Drug_metabolism_._cytochrome_P450 12 73 0.03604 0.1442
46 hsa04530_Tight_junction 19 133 0.03893 0.1524
47 hsa00604_Glycosphingolipid_biosynthesis_._ganglio_series 4 15 0.04417 0.1692
48 hsa04062_Chemokine_signaling_pathway 25 189 0.04566 0.1712
49 hsa00340_Histidine_metabolism 6 29 0.0473 0.1712
50 hsa02010_ABC_transporters 8 44 0.04756 0.1712
51 hsa04144_Endocytosis 26 203 0.05841 0.2061
52 hsa04340_Hedgehog_signaling_pathway 9 56 0.07204 0.2494
53 hsa00670_One_carbon_pool_by_folate 4 18 0.07939 0.2696
54 hsa04370_VEGF_signaling_pathway 11 76 0.09224 0.3075
55 hsa04115_p53_signaling_pathway 10 69 0.1044 0.3404
56 hsa04914_Progesterone.mediated_oocyte_maturation 12 87 0.1071 0.3404
57 hsa00280_Valine._leucine_and_isoleucine_degradation 7 44 0.1097 0.3404
58 hsa04962_Vasopressin.regulated_water_reabsorption 7 44 0.1097 0.3404
59 hsa04145_Phagosome 19 156 0.1353 0.4126
60 hsa00532_Glycosaminoglycan_biosynthesis_._chondroitin_sulfate 4 22 0.142 0.426
61 hsa00910_Nitrogen_metabolism 4 23 0.16 0.4722
62 hsa04666_Fc_gamma_R.mediated_phagocytosis 12 95 0.1702 0.4836
63 hsa00260_Glycine._serine_and_threonine_metabolism 5 32 0.1716 0.4836
64 hsa04114_Oocyte_meiosis 14 114 0.172 0.4836
65 hsa04260_Cardiac_muscle_contraction 10 77 0.1756 0.484
66 hsa00760_Nicotinate_and_nicotinamide_metabolism 4 24 0.1788 0.484
67 hsa00380_Tryptophan_metabolism 6 42 0.1914 0.484
68 hsa03320_PPAR_signaling_pathway 9 70 0.1999 0.484
69 hsa00072_Synthesis_and_degradation_of_ketone_bodies 2 9 0.2011 0.484
70 hsa04660_T_cell_receptor_signaling_pathway 13 108 0.2022 0.484
71 hsa04210_Apoptosis 11 89 0.2025 0.484
72 hsa04150_mTOR_signaling_pathway 7 52 0.2053 0.484
73 hsa00360_Phenylalanine_metabolism 3 17 0.2058 0.484
74 hsa00450_Selenocompound_metabolism 3 17 0.2058 0.484
75 hsa04614_Renin.angiotensin_system 3 17 0.2058 0.484
76 hsa00071_Fatty_acid_metabolism 6 43 0.2062 0.484
77 hsa00564_Glycerophospholipid_metabolism 10 80 0.2071 0.484
78 hsa04976_Bile_secretion 9 71 0.2115 0.488
79 hsa00310_Lysine_degradation 6 44 0.2215 0.5046
80 hsa00565_Ether_lipid_metabolism 5 36 0.2396 0.539
81 hsa00531_Glycosaminoglycan_degradation 3 19 0.2569 0.5709
82 hsa00512_Mucin_type_O.Glycan_biosynthesis 4 30 0.3029 0.6649
83 hsa01040_Biosynthesis_of_unsaturated_fatty_acids 3 21 0.3094 0.6711
84 hsa00561_Glycerolipid_metabolism 6 50 0.3192 0.6839
85 hsa00410_beta.Alanine_metabolism 3 22 0.3359 0.703
86 hsa04964_Proximal_tubule_bicarbonate_reclamation 3 23 0.3622 0.7495
87 hsa00603_Glycosphingolipid_biosynthesis_._globo_series 2 14 0.3788 0.7747
88 hsa00330_Arginine_and_proline_metabolism 6 54 0.3874 0.7789
89 hsa04973_Carbohydrate_digestion_and_absorption 5 44 0.3894 0.7789
90 hsa00770_Pantothenate_and_CoA_biosynthesis 2 16 0.4459 0.8724
91 hsa03022_Basal_transcription_factors 4 37 0.4549 0.8804
92 hsa00630_Glyoxylate_and_dicarboxylate_metabolism 2 18 0.5088 0.9694
93 hsa04744_Phototransduction 3 29 0.5137 0.9694
94 hsa00600_Sphingolipid_metabolism 4 40 0.517 0.9694
95 hsa00020_Citrate_cycle_.TCA_cycle. 3 30 0.5372 0.9866
96 hsa00650_Butanoate_metabolism 3 30 0.5372 0.9866
97 hsa00592_alpha.Linolenic_acid_metabolism 2 20 0.5668 1
98 hsa00010_Glycolysis_._Gluconeogenesis 6 65 0.5694 1
99 hsa00250_Alanine._aspartate_and_glutamate_metabolism 3 32 0.582 1
100 hsa04620_Toll.like_receptor_signaling_pathway 9 102 0.6153 1
101 hsa00140_Steroid_hormone_biosynthesis 5 57 0.6209 1
102 hsa04140_Regulation_of_autophagy 3 34 0.624 1
103 hsa04975_Fat_digestion_and_absorption 4 46 0.63 1
104 hsa04330_Notch_signaling_pathway 4 47 0.6471 1
105 hsa00590_Arachidonic_acid_metabolism 5 59 0.6517 1
106 hsa00980_Metabolism_of_xenobiotics_by_cytochrome_P450 6 71 0.6568 1
107 hsa04130_SNARE_interactions_in_vesicular_transport 3 36 0.663 1
108 hsa04672_Intestinal_immune_network_for_IgA_production 4 49 0.6797 1
109 hsa04142_Lysosome 10 121 0.6978 1
110 hsa00601_Glycosphingolipid_biosynthesis_._lacto_and_neolacto_series 2 26 0.7102 1
111 hsa04650_Natural_killer_cell_mediated_cytotoxicity 11 136 0.7291 1
112 hsa00620_Pyruvate_metabolism 3 40 0.7319 1
113 hsa00500_Starch_and_sucrose_metabolism 4 54 0.7517 1
114 hsa04146_Peroxisome 6 79 0.7546 1
115 hsa04120_Ubiquitin_mediated_proteolysis 11 139 0.7548 1
116 hsa00591_Linoleic_acid_metabolism 2 30 0.782 1
117 hsa04141_Protein_processing_in_endoplasmic_reticulum 13 168 0.7941 1
118 hsa00830_Retinol_metabolism 4 64 0.8575 1
119 hsa00270_Cysteine_and_methionine_metabolism 2 36 0.8603 1
120 hsa04742_Taste_transduction 3 52 0.8735 1
121 hsa03015_mRNA_surveillance_pathway 5 83 0.8949 1
122 hsa00240_Pyrimidine_metabolism 6 99 0.9076 1
123 hsa04110_Cell_cycle 8 128 0.9172 1
124 hsa00860_Porphyrin_and_chlorophyll_metabolism 2 43 0.9187 1
125 hsa00520_Amino_sugar_and_nucleotide_sugar_metabolism 2 48 0.9454 1
126 hsa00510_N.Glycan_biosynthesis 2 49 0.9497 1
127 hsa04621_NOD.like_receptor_signaling_pathway 2 59 0.9778 1
128 hsa03018_RNA_degradation 2 71 0.992 1
129 hsa04612_Antigen_processing_and_presentation 2 78 0.9956 1
130 hsa03008_Ribosome_biogenesis_in_eukaryotes 2 81 0.9966 1
131 hsa03013_RNA_transport 4 152 0.9997 1
132 hsa04740_Olfactory_transduction 7 388 1 1

Quest ID: 8f394b3726ff82be71141a365404021e